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A note on abbreviations

The abbreviation "ED" is used throughout the text to stand for
"Emergency Department". In some interviews, patients refer to the "ER",
or Emergency Room, as the Emergency Department was previously
known.
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Introduction

Sickle-cell disease presents a unique set of problems for the patientphysician relationship. From the patient’s standpoint, sickle-cell disease
represents a life-long, disabling chronic disease, which can lead to many
psychosocial difficulties and dependence on analgesic medications. From
the physician’s standpoint, the disease represents a profound failure of
modern medicine: despite exquisite understanding of the pathological
basis of the disease in abnormal hemoglobin, no treatment has yet been
found to substantially ameliorate the suffering caused by the disease, nor
to halt progression of the disease in most cases. In addition, no objective
method of diagnosing painful crisis yet exists, which places diagnosis
largely in the subjective realm.

These inherent difficulties in the patient-physician relationship are
exaggerated in the modern Emergency Department, in which a large
volume of patients with increasingly acute illness burdens both physicians
and patients. Furthermore, Emergency Departments are increasingly taxed
as they become the means by which many patients seek primary care for
relatively less acute illness. In this environment, patients who return
repeatedly, requesting pain medications but not responding over the long
term to any known treatment, run the risk of arousing suspicions of drug
dependence or drug-seeking among Emergency Department staff and
house officers. For the patient, the Emergency Department, especially in a
teaching hospital, is an often chaotic place in which treatment is likely to
be given by previously unfamiliar physicians.

One may hypothesize that in such an environment, a circle of
suspicion and frustration may develop. This theoretical circle might begin
with a small subset of sickle-cell patients whose disease has especially

Introduction

Page 2

severe manifestations, and who seek care frequently in the Emergency
Department. Some of these patients may become well known to
Emergency Department staff as requiring frequent and high doses of
narcotic analgesics. Irrespective of the actual prevalence of drug
dependence among patients, suspicions of drug dependence may arise,
leading to a tendency among Emergency Department physicians to limit
the prescription of narcotic analgesics to sickle-cell patients in general.
Thus, many sickle-cell patients in crisis may receive less than the quantity
of narcotic analgesics necessary to control their crisis pain. In such a
situation, their requests for additional pain medication may lead to
escalating suspicions of drug-seeking among ED staff and increased
limitations on prescription of narcotics. In this way a circle of suspicion
and frustration may begin to fuel itself.

The present study aims to investigate this hypothetical circle at
several points, and to gather the information necessary to organize
management interventions to interrupt it. To this end, the study will be
arranged in three parts:

1) a literature review, 2) an analysis of hospital

visits and admissions to YNHH during the period of a year, and 3)
interviews with a subgroup of patients who were the most frequent visitors
to the Emergency Department during the study year. In the discussion
section, a number of possible interventions will be discussed in light of the
results of the study.

Literature Review
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Literature Review

The difficulties of treating patients with sickle-cell disease have been
intensively studied ever since Herrick first definitively described the
manifestations of the disease in 1910. In this section, therefore, an
overview of the literature on sickle-cell disease will be given, concentrating
on factors which influence the interaction between the patient with sickle¬
cell disease and his or her health care providers.

This section will begin with a general discussion of the various
attempts by modern medicine to understand and treat sickle-cell disease.
After all, the relationship between doctor and patient in sickle-cell disease
has been conditioned to date by the intractability of the disease to all but
symptomatic treatment. In addition, modern medicine’s efforts to
objectively confirm the presence of sickle-cell crisis will be reviewed.
These efforts have been in three general areas: laboratory tests, physical
examination, and psychological testing.

Next, the literature on the doctor-patient relationship in general will
be briefly reviewed, with emphasis on the nature of the "sick role" assumed
by many patients with chronic disease. In particular, "Social Labelling
Theory", an area which concerns itself with the way in which medical
judgements or diagnoses in themselves affect patients’ lives and social
interactions, will be discussed.

Literature on psychological aspects of sickle-cell disease, especially as
regards the effects of chronic disease and pain on patients with sickle-cell
disease, will be reviewed in some detail. Special emphasis will be placed
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on "secondary gain" and adversarial relationships with health-care
providers.

Finally, pain control during sickle-cell vaso-occlusive crisis will also
be reviewed, concentrating on the role of narcotic analgesics and non¬
steroidal anti-inflammatory medications in sickle-cell disease.

A.

Medical issues:

1.

Frustration in treatment since discovery of the disease

a.

Historical issues

A look at the history of sickle-cell disease in modern medicine
reveals a good deal about the frustration felt by clinicians working with
this disease every day. After all, though it is a history of triumphs in
understanding the molecular basis of the disease, attempted treatments for
the disease have been either toxic or ineffective. Therefore, this section
will begin with a brief discussion of the discovery of the pathogenesis of
the disease. (').

Though syndromes now identifiable as sickle-cell disease had been
recognized by African peoples for many years previously (2), the disease
was first described to Western medicine by James B. Herrick, at a
conference. His full report was published in the Annals of Internal
Medicine in 1910 (3).

Herrick’s investigation had begun some six years

>
(

_

i

1 The review of this subject by Conley is the most extensive one available, see ConIey,x
1980
2 see the reports of Felix Konotey-Ahulu. cited in Conley, p. 319
3 Herrick, 1910
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earlier, during an examination of the blood from an anemic student from
the West Indies. After Herrick’s initial report, the clinical pattern was
established slowly, as case reports appeared over the next several decades.

In 1927 Hahn and Gillespie reported that sickling of the red cells
occurs when hemoglobin is deoxygenated, a great leap forward in
understanding the pathogenesis of the disease: "It is reasonable to suppose
that sickle cells are formed in the body of an affected person wherever the
oxygen tension and hydrogen ion concentration are such as to render the
distorted form of the corpuscles stable" (4). In 1933, L.W. Diggs presented
a remarkably complete description of the lesions seen at autopsy in a large
group of patients with sickle-cell anemia, and suggested a mechanism for
his observations: "A possible explanation of the capillary engorgement is
that the elongated and spiked cells interlock and pass with more difficulty
through narrow spaces than do normal cells." (5)

A tremendous breakthrough in the understanding of the sickling
process came during a conversation between William B. Castle and Linus
Pauling, on a train ride from Denver to Chicago in 1945. Pauling recalls
that Castle, in mentioning the birefringence of deoxygenated, sickled red
blood cells seen with polarized light, suggested that sickle cells might
"contain an abnormal kind of hemoglobin, which when deoxygenated has
the power of combining with itself into long rigid rods, which then twist
the red cell out of shape" (6). Pauling began to work on the problem with
his graduate students, and in 1949 he described the altered electrophoretic

4 Hahn, 1927
s Diggs, 1934
6 Pauling, 1955.
Note that Castle is modest in his own account of the same
conversation: "I am equally clear that I did not make the further generalization that
it was orientation of the hemoglobin that might be doing this [ie. causing
birefringence]" in Conley, p.339
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mobility of the hemoglobin of patients with sickle-cell anemia, and
ascribed the change to an alteration in the globin. With electrophoresis,
the group was able to prove that the red blood cells of those with sickle
cell "trait" contained both normal and sickle hemoglobin. Thus it was
proven that the person with sickle-cell trait was a heterozygous carrier of
the sickling gene.

It was in 1956 that Vernon Ingram combined electrophoresis and
chromatography in examining tryptic fragments of sickle hemoglobin, to
show that the abnormality lay in a single peptide. (7). In the years
following this discovery there was a tremendous burst of research into the
structure of hemoglobin, and by 1961 the entire primary structure of
hemoglobin had been elucidated. Thus it was discovered that the site of
the amino acid replacement in sickle hemoglobin is at the sixth residue of
the beta chain. As Conley puts it, the "first molecular disease" had been
discovered (8). After this, successes came quickly with the elucidation of
the position of the aberrant residue on the surface of sickle hemoglobin,
and with insights into deformation of the cell membrane by polymerized
sickle hemoglobin.

7 Ingram, 1958
8 Conley p. 346
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Clinical manifestations of siekle-cell disease

The investigation of sickle-cell disease is made more difficult by the
protean forms which sickle-cell disease may take in the individual patient.
In addition, different clinical syndromes are experienced by patients with
different combinations of the genes responsible for sickle-cell disease.

Patients who are heterozygous for the sickle gene (AS) possess one
copy of the sickle gene and one copy of the gene for "normal" hemoglobin
A. These individuals are said to have sickle-cell "trait", and generally
experience minimal clinical problems. Their overall life expectancy and
rate of hospitalization is the same as those of individuals homozygous for
hemoglobin A. Because their red blood cells contain enough hemoglobin
A to prevent sickling under most circumstances, they experience sickle-cell
crisis only when extremely dehydrated or hypoxic. Many patients with the
AS phenotype have impaired ability to concentrate urine, and a few have
painless hematuria due to infarction of the renal medulla, which is
especially vulnerable to sickling (9).

Patients who are homozygous for the sickle gene (SS) make no
hemoglobin A, and may experience an extremely wide range of clinical
manifestations, from mild to life-threatening, and in a variety of organ
systems. Starting from about six month of age (when fetal hemoglobin has
diminished enough to allow sickling by sickle hemoglobin), children with
sickle-cell disease have a general delay in growth and development, and an
increased tendency to develop infections, especially those due to
encapsulated bacteria such as pneumococcus. The function of the spleen,
which would normally remove such pathogens from the circulation, is

9

Bunn, 1987, p. 1519
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increasingly impaired by microinfarcts (10), until by adulthood only a
nubbin of fibrous tissue remains.

Adults who are homozygous for sickle hemoglobin have a severe
hemolytic anemia, with hematocrits in the 18 to 30 percent range. Mean
red blood survival is 10 to 15 days, as compared to a normal survival of
120 days. Because these patients are so dependent on ongoing production
of red blood cells, any infection w'hich affects erythropoiesis, such as that
of parvovirus, can result in aplastic anemia and a rapid drop in hematocrit.
However, the most characteristic syndrome affecting patients with sickle¬
cell disease is the vaso-occlusive "painful crisis", which can attack various
parts of the body, particularly the abdomen, chest and joints. About a
third of painful crises are preceded by a viral or bacterial infection.
Others appear to be precipitated by cold weather or by dehydration.

The extremely wide range of manifestations and complications of
vaso-occlusive crisis makes differential diagnosis difficult. It is often
difficult, for example, to differentiate between abdominal sickle crisis and
some other acute process such as biliary colic, appendicitis, or a perforated
viscus. Patients with abdominal crisis normally have no rebound
tenderness and normal bowel sounds, and if surgery is performed, no gross
evidence of infarction or ischemia is usually found. When sickle crisis
appears in the lung, it may either mimic, or be complicated by,
pneumonitis or pulmonary infarction. Similarly, when sickle crisis occurs
in the extremities, it may be complicated by osteomyelitis, or confused
with gout or rheumatoid arthritis. Patients with sickle-cell disease may
even present with cerebral manifestations such as stroke, seizure or coma.
In fact, vaso-occlusive crisis may affect almost any organ system,
particularly the lungs, kidneys, liver, skeleton, and skin. (n)

10

ii

see Pearson, 1985, p.392
See Bunn, 1987, p. 1520-21
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Among the various other variants of sickle-cell disease, an especially
important one occurs in patients who are doubly heterozygous for sickle
hemoglobin and hemoglobin C ("SC disease"). These patients have a mild
to moderate hemolytic anemia, and less frequent sickle crises. For
unknown reasons, patients with SC disease are especially vulnerable to
ocular complications, particularly proliferative retinopathy and retinal
detachment, as well as hematuria from renal medullary infarcts, and
avascular necrosis of the femoral head.

The protean manifestations of sickle-cell disease complicate the
doctor-patient relationship in a variety of ways. Clearly, the possible
presence of such complications as osteomyelitis or pulmonary infarction
can make for an extremely complex and expensive diagnostic workup,
which may nevertheless be completely negative. The choice of whether to
begin such a workup is very difficult, and may have to be based on
subjective criteria such as the patient’s expressions of pain. In a patient
suspected of simulating painful crisis in order to obtain pain medications,
the diagnostic uncertainty is even greater. After all, even a patient who
has shown irrefutable drug-seeking behavior in the past may still be at
genuine risk for a fatal sequel of sickle-cell disease in the present instance.

c.

Various attempts at treatment.

Treatment of sickle-cell disease has not been as spectacularly
successful as research into its underlying causes. Herrick reported success
with rest, nourishing food, administration of boric acid to leg ulcers, and
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the use of iodide, arsenic, and thymol. (12). Other treatments in the first
half of the century included splenectomy, liver diet, iron, blood transfusion
and a wide variety of other measures, none of which proved to be more
than transiently successful (13).

As the pathophysiology of the painful crisis began to be understood,
various attempts were made at prophylaxis. The reader is referred to
reviews by Charache and Conley (14) for a more detailed discussion of
these attempts at prophylaxis. Some successes were achieved, as, for
example, with partial exchange transfusions, which are still used to the
present day. However, because of side effects such as long-term iron
overload and the development of alloantibodies, the use of exchange
transfusion is limited to preparation for surgery and other stressful
situations, or the prevention of recurrent strokes. Similarly, oxygen was
found to be somewhat effective, but carried the danger of depression of
erythropoiesis and increased anemia (1S).

Most of these attempts at treatment, however, were total failures,
some of them spectacularly so. Nitrites and Carbon monoxide, for
example, were used in the hope that sickling could be prevented by the
resulting metnemoglobin and carboxyhemoglobin, but these treatments
could not be safely administered. Also tried were sodium bicarbonate and
sodium citrate, in the hope that increased pH would decrease sickling, but
could not be shown to be effective in controlled trials. Urea and Cyanate
as potential anti-sickling agents both generated tremendous excitement in
laboratories across the country, but proved to be either ineffective, toxic.

Herrick, 1910
Charache, 1974
Charache, 1974, pp. 698-705, and Conley, pp. 356-358
15

Charache, 1981, p. 195-196
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or both. Cyanate, in particular, caused a severe peripheral neuropathy, as
well as cataracts.

Even at present, treatments in use for sickle-cell disease do not
attempt to modify sickle hemoglobin at all. but rather, attempt to
ameliorate symptoms by causing an increase in production of fetal
hemoglobin (t6). For example, some elevation of fetal hemoglobin has
been achieved with the hematopoietic hormone erythropoietin, though the
most recent study on its effects did not show any significant benefit (17).
in addition, numerous cytotoxic drugs are known to increase production of
fetal hemoglobin. For example, it has been shown that 5-azacytidine could
stimulate dormant gamma globin genes in adults with sickle-cell disease,
thereby increasing production of fetal hemoglobin. Similarly, in several
studies with small patient samples, hydroxyurea has been shown to be
effective in causing elevated levels of fetal hemoglobin over long periods
with minimal toxicity, and with decrease in painful crises (18). However,
none of these therapies has been yet shown to do more than reduce
somewhat the frequency of painful crises; no known therapy can yet
reduce the severity of crisis when it does occur. At present, medications
such as hydroxyurea are considered experimental (19).

Platt, 1988
See Goldberg, 1990. Goldberg et als' trial examined the effects of ervthropoitin
alone and with hydroxyurea in 5 patients.
Charache, 1987. Recently Goldberg et al (1990) have achieved success in 5
patients in increasing fetal hemoglobin and decreasing the rate of hemolysis in
sickle-cell disease. Their trial of hydroxyurea also included erythropoietin, which
was not found to be beneficial.
Ironically, one of the most important medications in use against sickle-cell
disease, namely, penicillin, does not even affect sickle cell crises, but rather
protects against infections of pneumococcal and other encapsulated bacteria in
sickle-cell patients with decreased splenic function; that is, it "compensates for
the splenic paralysis sickling causes”. See Platt, 1988, p. 1479
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Thus, though promising treatments are on the horizon, treatment of
sickle-cell anemia remains at present about where it has been for decades,
with the mainstays of medical treatment being analgesia, oxygen, and
intravenous fluids (20).

d.

Programs to screen for Sickle-Cell Disease

Given the failure of any medical therapy so far to significantly alter
the course of sickle-cell disease, it is not surprising that various attempts
have been made to reduce transmission of the sickle gene. In fact, a
number of mandatory screening programs for newborns and adults were
begun in the early 1970’s, in the hope that genetic counseling of carriers of
the sickle gene would be effective in reducing the incidence of the disease
(21). However, most of these programs were poorly organized, and for
the most part offered little counselling or follow-up to people identified as
carrying the sickle gene.

Moreover, since prenatal diagnosis of the disease

was not available at the time, "prevention" meant advising affected blacks
not to have children, and was seen as having racist motivations (22).
Within a iew years, mandatory testing of black patients was on the wane.

Charache, 1974 and 1981, Platt 1988
President’s Commission, 1983, p. 21-22, and Stamatoyannopoulos, 1974, p.271
22

Robinson, 1973, p. 324. Also note that the use of penicillin as long-term
prophylaxis against encapsulated organisms in children did not begin on a wide
scale until Gaston’s report in 1986. See Platt, 1988.
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Lack of ability to verify sickle crises

Another area of intense research has been the search for an objective
test to confirm the presence of vaso-occlusive crisis. Considering the many
neurological, hematological and psychological factors which may influence
the pain of vaso-occlusive crisis, as well as the many medical
manifestations of crisis, it is not surprising that no test has been found
which is both sufficiently sensitive and sufficiently specific for routine
clinical use (23). There are three general areas in which research has
attempted to objectively differentiate the pain of "genuine" vaso-occlusive
crisis from "non-organic" pain, namely, laboratory examination, physical
examination, and psychological examination.

a.

Laboratory tests for Vaso-occlusive Crisis

Put briefly, there is no laboratory test to verify the occurrence of
sickle-cell vaso-occlusive crisis. However, several recent attempts have
been made. For example, Brownell has described the use of serum ferritin
levels as an indicator of sickle-cell crisis (24). The most obvious difficulty
with this approach is that, as an acute-phase reactant, ferritin levels rise in
a wide variety of circumstances. In an attempt to overcome the limitations
in specificity of laboratory tests taken singly, several writers have
employed combinations of measurements to confirm sickle-cell crisis. For
example, increases in percentages of dense cells, erythrocyte sedimentation
rate, fibrinogen levels. Magnetic Resonance Imaging and serum
prostanoids have all been used, in various combinations, to verify sickle-

Shapiro, 1989, p. 1031. Note also that it is still unclear what determines severity
of the disease in a given patient - on this topic see Schechter, 1982
24

Brownell, 1986
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cell crisis (25). None of these has been successful, and none is routinely
used in clinical practice.

b.

Physical Examination for Vaso-occlusive Crisis

Clinical methods to objectively distinguish "genuine" vaso-occlusive
crisis from "non-organic" pain have not been described specifically for use
in sickle-cell disease. The discernment of the organicity or non-organicity
of pain by physical examination would typically be considered in the realm
of "clinical intuition" (26). For example, "It is widely thought that pain
that never fluctuates in intensity of pain in a nonanatomic distribution
suggests the involvement of psychologic or learning processes" (27).
However, hard evidence for such views is lacking.

Work to clarify this issue has been done in the case of low back pain,
by Waddell. In his 1980 study, Waddell (2S) did not directly address the
issue of "organicity", but rather tested the ability of various findings in the
physical examination to predict the response of a patient with low back
pain to physical treatments or surgery. For example, the examiner may try

1)

rolling the skin of the patient over the lumbar spine, or

Lawrence, 1987 and Mankad, 1987
Bonica, 1990, p. 1457
Bonica. 1990, p. 597-98
28

Waddell, 1980
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lightly placing one’s hand on the patient’s head or rotating
the patient’s upper body (shoulders and hips together).

Since none of these maneuvers increase pressure in the lumbar spine,
complaints of pain by the patient on these maneuvers raise the suspicion
that the pain cannot be ascribed to a structural lesion in the spine. Other
findings include

3)

a significant discrepancy in pain between straight leg
raising in the seated and supine positions,

4)

non-physiological regional disturbances of sensation,
distribution of pain, or weakness, and

5)

over-reaction to the test stimulus, with excessive
verbalization, grimacing, or other "excessive" pain
behaviors.

Waddell showed that those patients with three or more positive
findings rarely responded to any physical treatment or to surgery. It is
important to remember, as Bonica points out, that "these are not tests of
malingering; they only indicate that the patient's pain behaviors cannot be
ascribed solely to structural lesions of the spine" (29).

The situation in sickle-cell disease is different than that of low back
pain in several respects. First, the pain of vaso-occlusive crisis may occur
in almost any area of the body, making specific "positive" findings on
physical examination difficult to describe. Second, in sickle-cell disease
there is no modality (as, for example, surgery in some kinds of low back

29

Bonica, 1990, p. 1458
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pain) successful enough in treating the underlying disease that patients’
response to it could be correlated with given findings on physical exam.

c.

"Objective" Psychological tests

Many attempts have been made to employ supposedly "objective"
psychological testing to identify those patients who are prone to "nonorganic” pain. For example, elevations in several subscales of the
Minnesota Multiphasic Personality Inventory, especially Hypochondriasis,
Depression, and Hysteria, have been noted in chronic pain patients (30).
These scores have been interpreted to mean that chronic pain patients are
characteristically preoccupied with their illness, unhappy, lacking in
psychologic insight, and tending to develop somatic symptoms in response
to stress and conflict (31). However, no single, pathognomonic pattern is
observed on MMPI among patients with chronic pain, nor, of course, can it
be established which, if any, of the chronic pin patients has an organic
cause for the pain.

A number of "objective" psychological indicators have been used to
assess psychological factors in sickle-cell disease, but none has been
successful in predicting clinical features of the disease in a given patient,
nor in characterizing "genuine" vaso-occlusive crisis. Psychological testing
of patients with sickle-cell disease will be discussed under "Psychology"
below.
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So far, we have reviewed the three main areas in which research has
attempted to objectively verify the presence of vaso-occlusive crisis - in
the laboratory, the examination room, and the psychologist's office. The
failure of these efforts has a profound effect on the doctor-patient
relationship, since it means that physicians cannot objectively differentiate
"true" sickle-cell crisis pain from pain of other causes, including factitious
pain in the context of drug-seeking. As with other conditions in which the
principle complaint is chronic pain, there is no "gold standard" for proving
"genuine" sickle-cell vaso-occlusive crisis.

The literature on "objective" verification of pain often phrases the
problem in terms of the patient, that is, it attempts to identify patients
whose pain is non-organic. Waddell’s system for identifying patients who
will not benefit from surgery is one example. However, such an approach
applied to patients with sickle-cell disease may give misleading results,
because the same patient who may fabricate the symptoms of a sickle-cell
crisis one week may have a "genuine" crisis the following week. In other
words, both "untrue" and "true" crises may occur at different times in the
same patient. Therefore, the "validity" of sickle-cell pain must be judged
anew for each sickle-cell crisis.

Literature Review
B.

Page 18

The Doctor-patient relationship in Sickle-cell Disease:

1.

General considerations

The patient with sickle-cell disease seeking care in the Emergency
Department of Yale-New Haven Hospital faces a large system developed
to evaluate and treat efficiently a great number of patients. Consequently,
the relationship between individual doctor and patient must be viewed in
terms of its position within that larger system. Therefore, it will be useful
to discuss the work of David Mechanic, who has examined the effects of
the "bureaucratization" of medical care in large medical institutions.

Mechanic points out the inherent conflict in the Emergency
Department situation between the need to be efficient and the desire to
provide care for patients’ social and emotional needs (32). Bureaucracy,
after all, "encourages specialized activity, routinized procedures and modes
of operation, [...] and there is a strong tendency for bureaucracies to try to
limit client control." (33) In addition, as medical institutions become
larger and more impersonal, a variety of intermediaries become interposed
between the patient and the professionals who control their care. In fact,
patients may even have difficulty ascertaining who is actually responsible
for their care (34). Thus patients may feel that they are facing an
impersonal system that does not understand their individual problems or
pain.
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Conversely, Mechanic points out that within a bureaucratically
organized medical system, physicians may feel equally frustrated. A
special source of difficulty for the physician is the "patient with a high
inclination to use medical care" (35) but no objectively verifiable basis for
his or her symptoms:

"There is no end to the depth of exploration that is theoretically
possible, and the dc +or knows that he must live with the fact
that it can never really prove that there is no underlying
physical basis. [...] At some point he must begin to consider the
risks of continued exploration: the dangers of the various
diagnostic procedures, the economic costs of continued
searching, and the probability that continued searching may
reinforce the attitude of the patient that he is indeed physically

Mechanic points out that physicians may in many cases feel that the
treatment they provide may have at best a problematic value for their
patients. Certain patients may develop an overdependence on physicians,
and may actually be "adversely affected by particular kinds of intensive
care and attention". (37). For example, "excessive focus on symptoms and
life difficulties may reinforce an already hypochondriacal pattern, induce
or encourage further displays of illness behavior, and bring about reduced
coping effectiveness." (3S).

In addition, such patients may be thought to

be exploiting the "sick role", with its exemption from social responsibilities

Mechanic p.426
Mechanic p.426
Mechanic, p. 431
38
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and obligations (39). Physicians may thus suspect that this exemption
from responsibilities is one more aspect of the "secondary gain" patients
may derive from their illness.

2.

The "Social labelling" Perspective on Illness

In studying the treatment of patients with sickle-cell disease, it is
essential to remember that most patients with the disease come in with the
diagnosis of sickle-cell disease, and that physicians will bear this in mind in
all subsequent medical decisions. In addition, the "illness label" of sickle¬
cell disease in itself can have profound effects on patients' lives,
irrespective of the symptoms of the disease at any given time. In this
context, it will be useful to discuss the sociological literature on "social
labelling", which describes the way in which medical judgements or
diagnoses in themselves affect patients’ lives and social interactions.

An overview of "Social Labelling Theory" can be found in a 1981
review by Nancy E. Waxier. She suggests that

"A person is labelled as ’ill’ in the course of social negotiations
between himself, his doctor, his family, and sometimes ward
staff and others. The outcome of such social negotiations is
influenced by each person’s beliefs and training and also by the
social and organizational contexts in which the negotiation
occurs. Once labelled as ’ill’, the individual may find himself
caught in the midst of a self-fulfilling prophesy". I40)
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Thus, for example, a diagnosis of mental retardation 'labels' a patient
in the eyes of many as having a profound disability, and may profoundly
change that person’s social relationships and future possibilities.

However,

as suggested in a 1973 study by Mercer, some parents, especially middleclass white parents, manage to "negotiate" another diagnosis to keep their
children in normal classes, or simply send their children to a private or
parochial school. Thus, the diagnosis of mental retardation ended up being
disproportionately applied to black and hispanic students. (41)

Similarly, individual patients may choose to adopt or discard a label
of "illness", based not only on symptoms, but also on the patient’s social
and economic background. A good example is found in a 1968 study, by
Ludwig and Adams, of patient cooperation in a general rehabilitation
center. It was found that among all physically disabled people in the
program, the ones most likely to drop out before completion of the
program, against physicians’ advice, were Caucasians, men, the middle
aged, and those with previous employment. Conversely, those more likely
to complete the program were blacks, women, the very old and very
young, and the unemployed. Thus, the data appear to suggest that those
who were in the most powerful social position, and those who had
employment to return to, were most able to declare themselves "normal"
by dropping out of the treatment system. On the other hand, those in a
less powerful social position, and those with no employment, seem to have
had more reason to continue (or less reason to discontinue?) their "sick
role" in treatment. (42)
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Characteristics of the institution also influence the application of the
label of "illness". For example, the desire of a given institution to admit a
patient formally (and thereby substantiate the patient's "illness") may be
determined by the number of beds available at the time. In a 1975 study,
Harris found that increases in the number of hospital beds in 56 counties
in New York State led to increases in the number of patients in the
hospital, not because of any increased need, but because physicians
responded to the new, empty beds by increasing admissions and
lengthening hospital stays (43). Similarly, the financial situation of a
hospital, and the expected reimbursement from the patient or his insurance
company, may influence the decision whether the patient is "sick enough to
be hospitalized" C44). A patient with no insurance, for example, might
conceivably be less likely to be admitted than a patient with insurance for
the same illness.

The arguments of the "social labelling theory" can be applied in
different senses to sickle-cell disease. Certainly, the presence or absence
of sickle hemoglobin (hemoglobin S) is not "negotiated", and refutes the
more extreme "social labelling theorists", who seem to imply that the
labelling process "creates" the disease (45). In fact, the irrefutable
presence of hemoglobin S in the red blood cells of patients with sickle-cell
disease unavoidably conditions the entire interaction between an affected
patient and his or her physician.

However, the presence or absence of vaso-occlusive crisis is
"negotiated" in a very real sense, since it is usually entirely subjective,
experienced by the patient but not verifiable by the physician. It is in this
sense that "social labelling theory" can be most easily applied.
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The "Gomer phenomenon"

In this context, it is important to note that institutions may spawn a
different, less formal sort of "label" for patients, not known to the patient,
nor, for that matter, well known to the world outside the health care
system. The term "GOMER" is a classic example, which is discussed in a
1985 article by Leiderman and Grisso. This term may have a special
relevance to the care of patients with sickle-cell disease, whose care
presents many difficulties.

First popularized in the novel House of God by Shem, "Gomers"
appear as patients who frustrate the housestaffs every effort to ameliorate
their condition. Leiderman and Grisso studied the way the term is used in
an actual hospital by comparing a group of 18 "gomers" (as identified by
housestaff) with a matched control group of "non-gomer" medical patients.

In Leiderman and Grisso's study, the image of the "gomer" which
emerges is not a simple stereotype: "Gomer is neither a class-linked nor
race-linked pejorative term, nor is the term applied merely to malingering,
self-destructive patients" (46). However, "gomers" distinguished
themselves from medical patients in the control group by the special
frustrations which their illnesses and management posed for resident
physicians: "Gomers suffered irreversible mental deterioration; their
illnesses were complex and intractable; they were unable to resume
normal adult social roles; and they had no place to go after discharge"
(47)
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Leiderman and Grisso, p. 294
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Such patients have special importance to the reside t physician: 'The
lingering presence on acute medical wards of patients for whom modern
medicine can provide no therapy, or frequently even diagnosis, challenges
physicians’ ideals about the powers of medicine" (48).

in addition,

"Gomers" rarely offer the resident physician an "interesting case", that is,
one with educational value to the physician in training (49). Leiderman
and Grisso suggest, however, that the situation may be different for the
attending physician, who is "protected from the frustration, helplessness,
and uncertainty that these patients generate".

In fact, senior physicians

have been known to severely censure housestaff for the use of epithets like
"gomer" (50).

Leiderman and Grisso’s article has the potential for application to
patients with sickle-cell disease. With their multiple medical problems,
sickle-cell patients require considerable effort by the housestaff, who are
heavily involved in their care. Their illness is complex and intractable, and
often is so disabling that normal adult social roles are impossible.
Nevertheless, sickle-cell disease permits a relatively long life, and patients
return again and again with frequently similar, inscrutable pain. As
described above, few' therapeutic options are available beyond analgesia
and hydration. Response to therapy is most often slow and incomplete.
Neither are patients with sickle-cell disease often "interesting cases". In
short, patients with sickle-cell disease fulfill many of the criteria for the
role of "Gomer".

Leiderman and Grisso, p. 294
Leiderman and Grisso, p. 29S
Leiderman and Grisso, p. 295
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The "Undesirable Patient"

In considering the nature of possible conflict between the patient
with sickle-cell disease and his or her physician, it will be useful to have a
framework for categorizing issues which lead to conflict. A useful article
in this context was written in 1970 by Solomon Papper. He discusses the
various types of "undesirability" which can make a patient unpleasant to his
or her physician. (51)

In Papper's scheme, qualities of patients "undesirable" to physicians
can be broken down into five general groups:

1)

Socially undesirable: this category includes, for example,
alcoholic, dirty, uneducated, very poor patients, as well as
patients belonging to certain ethnic or religious groups.

2)

Attitudinally undesirable: for example, patients who "think they
know too much", or who otherwise questions the physician's
authority, or generally, those whose attitude frustrates the
physician: 'The problem here is the patient’s lack of knowledge
of, or failure to meet, the physician's expectations or needs"
(52)-

3)

Undesirability on "physical" grounds: includes patients who lack
a diagnosable physical illness or who do not respond to
treatment (for example, "crocks"), and patients who have
chronic (especially malignant) or simply "ordinary" (ie not
"interesting") diseases.
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Circumstantial undesirability: for example, the patient who
arrives late, or on a busy clinic day.

5)

"Distraction" undesirability: for example, the patient who does
not fulfill criteria for inclusion in the physician's research study,
or who distracts him from his research.

Papper's scheme will be helpful in considering the nuances of conflict
between doctor and patient. In the case of sickle-cell disease, patients may
fit into more than one category of "undesirability", as seen by their
physicians.

C. Psychological issues

1.

Introduction

Psychological issues in the care of patients with sickle-cell disease are
pivotal. After all, patients with sickle-cell disease are susceptible to all the
difficulties of having a chronic, often painful, unpredictable disease with
many ramifications for patients’ occupational and social lives. Therefore,
in this section a brief overview will be given of the literature on
psychological issues in sickle-cell disease. Then will follow a more detailed
look at six leading articles on the subject, written from 1976 to 1989.

The pain of sickle-cell vaso-occlusive crisis can be overwhelmingly
stressful to patients. In fact, one writer, Barbara Shapiro, has compared the
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intense, unpredictable pain of sickle-cell crisis to that experienced in the
"learned helplessness" phenomenon in animals (53).

For all the pain they experience, children do not seem to become
seriously "psychosocially impaired". In fact, children with sickle-cell
disease tested with various psycho-social instruments seem, with a few
differences, to be remarkably similar to healthy children of similar age and
socio-economic status (54). Evidence seems to indicate that difficulties in
psychosocial functioning seem to increase during adolescence, especially in
young males (55).

Similarly, adolescence appears to be the time when adversarial
relationships are most likely to develop between the patient with sickle-cell
disease and his or her physicians and nurses (56). Puberty, difficult
enough for healthy young people, may be especially difficult for both the
patient and his health care providers. Barbara Shapiro, for example, has
pointed out that adolescents with sickle cell disease must work through the
usual developmental issues, which are marked by "intensive and often
perplexing limit-seeking" (57).

Shapiro, 1989, p. 1032
Kumar, 1976, discussed below and Lemanek, 1986
Leavell, 1983. discussed below, and Hurtig, 1986
Vichinsky, 1982, discussed below
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Going to the hospital for treatment of sickle pain is a learned
behavior, which is influenced by a number of variables, including the
patient's age. experiences during previous hospitalizations, home
environment and support, and economic situation (58). Thus, it is not
surprising that there is wide variation patients’ propensity to use hospital
services. Some patients are quick to visit a doctor at the onset of pain,
while others attempt to manage even the most severe crisis at home. So, it
is important to remember that the frequency of use of emergency services
and the number of hospitalizations may not reflect the actual severity of a
patient’s illness.

Adults with sickle-cell disease appear to have a greatly increased
prevalence of psychiatric and psychosocial impairment when compared to
patients with otherwise similar socioeconomic status and severity of
chronic illness, as discussed below (59). Patients with sickle-cell disease
have been compared to patients with diabetes i60) and with asthma (61)
(both discussed below).

A more detailed discussion of six leading articles on psychological
aspects of sickle-cell disease will now follow.

Shapiro, 1989, p. 1033
Damlouji, 1982 and Leavell, 1983, both discussed below
Damlouji, 1982, discussed below
61

Bobo, 1989, discussed below
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Psychological issues: a more detailed look at six articles

a.

Kumar, 1976

Santosh Kumar et al (62) studied a group of 29 adolescent children
with sickle-cell disease, ages 12-18 years, selected apparently randomly
from among patients making visits to the hematology clinic at the Los
Angeles County/University of Southern California Medical Center (the
article does not make clear how this sample was chosen). There was also
a control group of 26 children drawn from a local high school, of the same
age range and ethnic background. The subjects were given a battery of
tests, including the "General Anxiety Scale for Children", the "Piers-Harris
Self-Concept Scale", and the "California Test of Personality".

Results of these tests indicated that patients with sickle-cell disease
are

"no different from the comparison group without sickle cell
anemia on personal, social, and total adjustment scales. [...]
The patients show significantly higher tendencies to withdraw
(be lonely) than the comparison subjects on the personal
adjustments. The patients also had significantly low'er social
skills (liking for people, inconveniencing oneself to be of
assistance to others, being diplomatic in one's dealing with both
friends and strangers) than did normal subjects. The mean
score for self-concept was significantly lower than that of the
comparison group." (63)
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Interestingly, patients with sickle-cell disease scored lower on the anxiety
scales than did normal students.

Kumar et al conclude that though patients with sickle-cell disease
who have had consistent family support and health care are not different
from a matched peer group in adjustment, as judged by the tests given.
However, patients showed a lower "self-concept", and thus might benefit
from "guidance and especially reassurance to strengthen self-confidence"
(M).

b.

Barrett et al, 1988

Drue H. Barrett et al (6S) studied a group of 89 adult patients with
sickle-cell disease being seen at a sickle-cell center at a hospital in
Georgia. Barrett et al used the "Chronic Illness Problem Inventory" (CIPI)
to assess psychosocial impairment in a range of areas, and also collected
data on the number of acute emergency visits per month.

Results of the "CIPI" showed that patients rated as most severe their
problems with employment, followed by sleep, eating, and financial
difficulties. In addition, patients reported difficulty in the areas of Body
Deterioration, Activities of Daily Living, and Assertion. The lowest
problem severity ratings were found in the scales of Physical Appearance,
Cognition, and Marital Difficulty.

Men scored higher than women on 17

of the 18 scales, though not to a statistical significance of P < .05.
Interestingly, there did not appear to be a correlation between scores on
the "CIPI" and utilization of emergency services, years of sickle-cell
disease, or age of the patients.

Kumar, p. 862
65

Barrett, 1988
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Barrett et al conclude that the studied population of patients with
sickle-cell disease was having significant psychosocial distress, especially in
the areas of employment, sleeping, eating, and finances, as well as in other
areas. Although depression was not specifically measured, the authors
speculate that their data may imply that "depression may be prevalent
among this population” f66). They suggest that vocational rehabilitation
and job training programs might benefit these patients.

c.

Leavell et al, 1983

Sandra R. Leavell and Charles V. Ford (67) studied 16 adults with
sickle-cell disease, including 8 men and 8 women, between the ages of 19
and 53 (mean age 32), recruited in an unspecified fashion from two
university hematology clinics in Nashville. The authors used a structured
interview to assess mood, personality, education and background in the
patients, and also employed the "State-Trait Anxiety Inventory" (STAI) and
the "Schedule for Recent Events" (SRE). The "SRE" yields "Life Change
Units" (LCU's) as a measure of recent life changes and stresses. The
authors also attempted to contact the patients six months later to ascertain
whether they had experienced symptoms of sickle-cell disease in the
interim.
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Results from the interviews and tests indicated that there was no
consistent "specific characteristic personality or behavior problem
associated with sickle-cell disease". However. 8 of the lb patients were
diagnosed with a "psychiatric disorder", including among other diagnoses
sociopathy, history of substance abuse with hallucinations, drug-seeking,
and depression.

In particular, "psychiatric impairment" was greater in men

than in women.

Medical complications experienced by patients before the

study were also more severe with males than with females. In addition,
those patients who had had high stress (increased LCU’s) in the previous 6
months, and those with low social support, were more likely to report
having experienced symptoms of painful crisis in the 6-month follow-up
period I68). Finally, "State-Trait Anxiety Inventory" scores for the 16
patients were not significantly different than those reported earlier for
general medical patients (69).

Leavell and Ford conclude that their data did not suggest a "specific
characteristic personality or behavior problem associated with sickle-cell
disease (such as manipulative, narcotic-seeking behavior), but rather a
wide range of different types of personal adjustment to the disease" (70).
Regarding the lower levels of both medical complications and psychiatric
symptoms among women, the authors speculate that "women with sickle¬
cell disease who survive to adulthood are less disabled and therefore have
a more 'normal' idjustment to life in spite of their disease" (71). Finally,
they note that life stress, as well as lack of social supports, appears
associated with increased symptoms of sickle-cell disease.

See Leavell, 1983, p.28-29
Leavell, p. 25-29
Leavell, p.29
Leavell, p. 29.
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Note that the authors do not give figures on how many of their
female patients had had children. One wonders what effect pregnancy,
which in sickle-cell disease has a high rate of complications, might have
had on the authors’ assessment that psychiatric morbidity was less in their
female patients.

d.

Damlouji, 1982

Namir F. Damlouji et al (72), compared 30 patients with sickle-cell
disease with an age-, sex- and social-class-matched group of 30 patients
with diabetes mellitus, all of them black, aged 15-56, from inner-city
neighborhoods, recruited from patients seen at the Sickle-cell and Diabetes
Clinics at The Johns Hopkins Hospital. The authors administered the
"Social Functioning Schedule" (SFS) in a semi-structured interview, and the
"General Health Questionnaire" (GHQ) to all patients in the study. In
addition, the authors counted the number of medical complications noted
in the charts of both groups of patients.

Damlouji et al found that both sickle-cell disease and diabetes
mellitus were associated with social disability and psychiatric morbidity.
Overall, the patients with sickle-cell disease had more difficulties than the
patients with diabetes mellitus in 4 of the 12 scales of the "Social
Functioning Schedule" (employment, financial problems, child care, and
spare-time activities). There were no significant differences noted between
the scores of men and of women. Overall, in both groups of patients, the
authors note that although social maladjustment (ie "SFS” scores) and
emotional disturbance (ie. "GHQ" scores) correlated with one another.

Damlouji, 1982
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they did not directly correlate with the number of medical complications
(77). Neither could age, marital status, nor educational level be shown to
be associated with social maladjustment or emotional disturbance.

Damlouji et al speculate that factors which might have contributed to
the social disability and emotional disturbance tested in their patients with
sickle-cell disease and diabetes mellitus might have included "chronicity of
illness, lifelong and chronic dependence on the medical care system, and
the fact that both sickle ceil anemia and diabetes are incurable". The
authors suggest that the greater difficulties reported by patients with sickle¬
cell disease might have its basis in the fact that "the frequency and severity
of painful crises are both unpredictable and out of the patients' control" in
sickle-cell disease (74).

They also conclude that social maladjustment and emotional
disturbance may be independent of physical condition (as judged by
number of complications). However, their argument on this point is
weakened by their failure to define how they counted "medical
complications". Did they, for example, count "functional asplenia" in the
same way as they did "cerebrovascular accident"? No clue on this point is
given in the article.

Damlouji, 1982, p. 931
Damlouji, p. 931
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Bobo et al, 1989

Loretta Bobo et al (7S) studied a group of 108 patients from the
inner city of New Orleans, ages 15 and up, 48 of which had sickle-cell
disease, and 60 of whom had asthma, as well as 50 of both groups’
unaffected siblings. Bobo’s group interviewed the patients by telephone,
and employed selected scales from the Rand Health Insurance study to
assess the patients’ attitudes about prior and current health, health outlook
and worry/concern, resistance or susceptibility to illness, as well as
rejection of the sick role and attitude about doctors. In analyzing the data
collected, the authors looked both at each of these groups separately, and
at the aggregate of patients with sickle-cell disease and with asthma (ie the
"chronic disease group”).

Bobo et al found that health perception scores were significantly
lower for the chronic disease group than for their unaffected siblings on all
scales. In addition, the patients with sickle-cell disease reported
significantly poorer health than the asthma patients in half the scales,
including "health outlook", "resistance/susceptibility", and "sickness
orientation". Both the patients with sickle-cell disease and patients with
asthma reported high ratings of their own attempts to "reject the sick role"
(eg keep going, fight their disease), comparable with their siblings’ ratings.

When asked to give their opinions of the medical care they received
(in terms of access, continuity, financing, humaneness, quality of care and
satisfaction), both chronic illness groups, as well as their healthy siblings,
gave largely similar ratings overall. The only statistically significant
differences among the groups were significantly lower ratings given by
sickle cell patients in comparison to ratings by asthma patients in two of
the scales: humaneness of care (59 vs 65) and satisfaction with care (58

Bobo, et al, 1989
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vs. 64). However, patients with sickle-cell disease did not report any more
difficulty with access to health care, or with the costs of medical care, than
did the patients with asthma or the group of health siblings.

Bobo et al give several reasons why patients with sickle-cell disease
might report lower levels of health perceptions and opinions of medical
care in several scales. Given that patients did not report more difficulty
with access to health care than the asthma patients or healthy siblings
groups, Bobo et al speculate that 'These unfavorable ratings may have
been influenced more by the chronic disease than the impact of services"
(76). Thus, factors such as the recurring, unpredictable pain crises and
early mortality of sickle-cell disease may have contributed to differences in
the experiences of patients with sickle-cell disease and with asthma.

However, the authors mention another factor possibly contributing to
negative opinions of medical care in this case, namely, the recent
discontinuation (for lack of funding) of a special clinic for patients with
sickle-cell disease (77). Patients who had received comprehensive care at
the clinic were suddenly forced to rely on the emergency department and
outpatient clinics of the public hospital.

Unfortunately, the study by Bobo

et al. did not address specifically in interviews with patients what effect the
discontinuation of the clinic had on their views of their own health and of
the health care system (78).

Bobo, p. 11
Bobo, p. 12
Bobo et al cite an article which is helpful in considering this question. Nicole
Lurie and colleagues studied the effects on patients of termination from
California’s Medi-Cal program for indigent adults. The same study instrument,
from the Rand Corporation Insurance Study, was used by Lurie’s group, to
demonstrate a fall in health perceptions after termination of Medi-Cal benefits.
See Lurie, 1984 and Lurie, 1986
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Vichinsky, 1982

Elliot Vichinsky and colleagues have done particularly useful
research into the psychology of the doctor-patient relationship in sickle-cell
disease (7<>). In examining the conflicts surrounding the treatment of
sickle-cell disease at their hospitals in Oakland and Berkeley, California,
Vichinsky et al found that housestaff felt "marked anxiety surrounding the
evaluation of pain" in patients with sickle-cell disease. Conversely, the
authors found dissatisfaction among patients with the care they received
during sickle-cell crisis.

Reviewing the records of painful events requiring narcotic analgesia
(a total of 1,295 painful events) in 152 patients in the previous year, the
authors located the 31 patients of this group with the most crises and
evaluated each one of them with a psychiatric examination. This
preliminary data suggested that "depression, anxiety, and neuroses were
frequently present in the chronically ill sickle cell disease patient" l80).
Among other findings, psychiatric examination showed that "25 patients
(80%) had clear-cut characterologic neuroses, including depression,
hysteria, and hypochondriasis" (8I).

In addition, Vichinsky et al studied the records of 101 patients
receiving narcotic analgesics at their institutions (they do not clarify how
this sample was chosen) in an effort to identify narcotic-related
complications. The authors found that 6 patients had had "major motor
seizures precipitated by large doses of demerol", 3 patients attempted
suicide by drug ingestion (one died), 7 patients had "drug dependence", and
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3 had "drug addiction” (82). No clarification is given about how these
categories were defined in the chart review.

Interestingly, of the 1295 painful events reviewed, all initially thought
to be sickle-cell crisis, reviewed by Vichinsky et al, 31 episodes (ie 2%)
were subsequently found to have had other causes. Of these, 6 proved to
be cholecystitis, 5 to be metastatic pancreatic cancer (83), 4 to be deep
vein thrombosis. 2 episodes proved to be due to acute narcotic withdrawal

O.
Vichinsky et al conclude that depression, anxiety, and neuroses are
prevalent among patients with sickle-cell disease. After their initial review
of the psychology of patients with sickle-cell disease in their institutions,
the authors instituted a comprehensive program to coordinate pain
management in sickle-cell patients. This program is discussed below under
'Treatment of Sickle Cell Disease in the Emergency Department".

Vichinsky, p. 330, table 3

\

v

It is not made clear in the article whether these 5 episodes of pain from
metastatic pancreatic cancer were in the same patient
84

Vichinsky, p. 330, table 4
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Psychological issues: conclusions

The six studies reviewed above are quite disparate in their
approaches. Though five of the six studies employed at least one scalar (ie
quantifiable) measure of personality, adjustment or psychological well¬
being, not one of these scales was employed in more than one study. In
addition, patient samples and definitions of terms were different in
different studies. Therefore, comparison of results among the six studies is
difficult.

Age appeared to have a strong effect on psychological morbidity in
sickle-cell disease. Whereas Kumar’s sample of adolescents with sickle-cell
disease was similar to a matched control group in terms of general
adjustment and other measures, psychiatric morbidity in adult patients in
other studies was prevalent. These adult patients reported difficulties with
sleep, financial problems and body deterioration (Barrett), social disability
and emotional disturbance (Damlouji), low health outlook, sickness
orientation and dissatisfaction with medical care (Bobo). Patients in two
studies reported that problems with employment were especially severe
(Barrett and Damlouji).

In two studies discussed above, sickle-cell patients were found to
have greater psychological impairment than their peers with other chronic
diseases, including diabetes mellitus (Damlouji) and asthma (Bobo). The
authors cite a number of possible reasons for this marked psychological
impairment in sickle-cell disease relative to other chronic diseases,
including the early onset of illness in sickle-cell disease, the frequency and
severity of painful crises, and the early mortality of sickle-cell patients.
Perhaps most important, patients with sickle-cell disease have very little
control over their illness, as painful crises thus far are both unpredictable
and unpreventable. This is in contrast to diabetes mellitus, which can be
largely controlled (at least in the short term) by insulin and diet, and to

Literature Review

Page 40

asthma, in which bronchodilators and other therapies can markedly reduce
morbidity.

Two of the studies (Leavell and Vichinsky) employed structured
interview and psychiatric exam to assess psychiatric health of sickle-cell
patients. In Leavell’s study, 8 of 16 patients were found to have a
psychiatric disorder, including sociopathy, history of substance abuse with
hallucinations, drug-seeking and depression. In Vichinsky’s study, 25 of the
31 patients with the most crises were found to have characterological
neuroses, including depression, hysteria and hypochondriasis. Thus, though
both Leavell and Vichinsky found psychiatric morbidity prevalent in their
patients, neither found any specific type of psychiatric difficulty which was
singular to patients with sickle-cell disease.

In investigating the relationship between the patient with sickle-cell
disease and his or her physician, one may ask whether or not the
psychological stresses and impairment of sickle-cell disease predispose
patients to dependence on pain medications. Unfortunately, the literature
on the psychology of sickle-cell disease is not clear on this point. Though
psychiatric morbidity appears common, it is so diverse in nature that no
common thread leading to drug dependence can be identified. The topic
of drug dependence and its prevalence among sickle-cell patients will be
discussed further below.
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Analgesics

The literature on the treatment of sickie-cell pain is relatively broad,
and considerable disagreement exists about the value and dangers of
different classes of analgesics in treating the disease. Therefore, a brief
overview of the literature on pain relief in sickle cell disease will be
presented here, concentrating on the use of narcotic analgesics, especially
in the Emergency Department setting.

In dosing analgesics for patients with vaso-occlusive crisis, an
understanding of the pharmacokinetics of various analgesics is pivotal. As
Vichinsky points out, "duration of action of analgesia" refers to the period
during which the patient experiences analgesia. This period is not
necessarily the interval of adequate pain control l85).

Peripherally acting oral analgesics have a role in mild or moderate
pain of sickle-cell disease. For example, acetaminophen is a commonly
used agent, especially in children l86). In addition, aspirin and other non¬
steroidal anti-inflammatory drugs may be used in children who are afebrile
and without signs of infection, and may be especially helpful in bony pain
(87). In one controlled study, the non-steroidal anti-intlammatorv agent
diflunisal reduced pain towards the end of vaso-occlusive episodes, but not
during the period of most intense pain at the beginning of the episode
(**).

See Vichinsky, 1982, p. 33 i
Pearson. 1984
Shapiro, 1989, p. 1034
88

Perlin, et al. 1986
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For more intense pain, however, more powerful, narcotic analgesics
are often necessary, starting with oral agents. On the weaker end of the
spectrum of narcotic analgesics is oral codeine, which is often prescribed
with a peripherally acting analgesic (89). Codeine would most commonly
be prescribed for outpatient management of moderate pain f90).

Stronger opioids which can be given orally include hydromorphone,
oxycodone, methadone, and immediate and sustained-release morphine.
These oral medications may be used even for the management of severe
vaso-occlusive crises (91), with an analgesic effect comparable to that of
parenteral medications. Use of oral narcotics has been described in the
Emergency Department, but admission may still be necessary for proper
adjustment of dosage of monitoring of the patient (92). Nausea and
vomiting may limit the usefulness of the oral narcotic agents. In addition,
poor absorption of morphine may limit its use as an oral agent.

If admission and treatment with parenteral medication is necessary in
vaso-occlusive crisis, morphine is considered an especially good choice
(93).

However, if untoward effects such as pruritus, nausea and vomiting

occur and are persistent, another agent such as hydromorphone may be
chosen.

Though meperidine is often prescribed for management of severe
vaso-occlusive crisis, a number of dangers are associated with its use in

Shapiro, 1989, p. 1034
Pearson, 1984, and Vichinsky, 1982
Friedman EW, 1986
Friedman EW, 1986 and Shapiro, 1989
93

Vichinsky, 1982, p. 331 (table 5) and Shapiro, 1989, p. 1035

Literature Review

Page 43

patients with sickle-cell disease (94). Meperidine has a long-acting
metabolite (normeperidine) which has only slight analgesic activity, and
has been associated with excitation of the central nervous system,
dysphoria, and seizures (95). Excretion of normeperidine into urine is
decreased when urine is alkaline, which could lead to accumulation of this
metabolite in the renal tubular acidosis of sickle cell disease (%). In
addition, in one study meperidine levels in patients with sickle-cell disease
were lower than those in control patients, though both groups had received
the same amount intramuscularly (97). Thus, meperidine, at least when
given by the intramuscular route, may be less effective in relieving pain in
sickle cell patients than in other patients.

For patients in vaso-occlusive crisis who need parenteral analgesia,
Vichinsky recommends a fixed dosing interval for morphine of 2.5 hours
(at .15 mg/kg), to provide a constant level of analgesia. After the first 48
hours, the dose can usually be tapered. Once the dose of parenteral
morphine has been lowered to half the initial dose, Vichinsky recommends
switching to an equianalgesic dose of oral narcotics given every 4 hours

(*).
Cole and colleagues report on the use of continuous intravenous
narcotic infusions for the treatment of painful crisis in children ("). They
studied a total of 98 painful crises in 38 patients. Of the 98 episodes of
painful crisis, 76 were treated with continuous infusion of opioids

Shapiro, 1989, p. 1035
Tang, 1980
Szeto, 1977, and Shapiro, 1989
Abbuhi, 1986
Vichinsky, 1982, p. 331
99

Cole, 1986
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(morphine or meperidine) given on a standard protocol, and 22 were
treated with intermittent intravenous bolus injections of meperidine. The
authors found that patients given continuous infusions required more
narcotic to control their pain and had more side effects than those treated
with bolus injections alone (,0°).

Side effects of continuous intravenous narcotic infusions reported by
the authors included nausea and vomiting, lethargy, and abdominal
distention, as well as a significant incidence of chest syndrome, and severe
respiratory distress in three patients. They note that "narcotic withdrawal
or addiction was not observed" (101). Despite the many ill effects seen
with continuous opioid infusion, the authors conclude that this modality is
safe and provides adequate pain relief during vaso-occlusive crisis.

Patient-Controlled Analgesia (PCA) has been tried on a very limited
basis for patients with sickle-cell disease. For example, Schechter et al
have reported on a preliminary trial of PCA with adolescent patients, in
preparation for a randomized controlled clinical trial. (102). Their sample
consisted of only 3 patients, aged 12, 11, and 17 years old. The authors
found that doses of morphine required for pain control were higher than
expected.

However, morphine requirements decreased on successive days

as the pain crisis resolved, which was taken by the authors to imply that
the drug was not being abused (103).

The authors argued that use of PCA broke the cycle of
undermedication of sickle-cell pain, in which continued pain leads to a
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"seemingly undue interest in medication" by the patient, leading to
suspicion of drug-seeking by the physician and continued undermedication.
Interestingly, the authors believe that "deeply entrenched attitudes" in the
medical profession toward patients with sickle-cell disease led to the
refusal of one hospital to participate in a clinical trial of PCA for patients
with sickle-cell disease (l04)

It is important to note that even if Patient-Controlled Analgesia is
not available, many of the same advantages can be gained with a flexible
dosing schedule (105).

Because there are no prospective, controlled studies comparing
opioids and routes and schedules of administration in sickle-cell disease
(106), it is difficult to make a definitive judgement on the efficacy of one
versus the other. The reader is referred to the literature cited above for
more detail on this subject.

Schechter et al, 1988, p. 112. It might be noted that at the particular hospital
cited by Schechter et al, PCA was already an established modality for treatment
of post-operative pain.
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Narcotics addiction in patients with sickle-cell disease

Because "addiction" to narcotics is defined in so many ways, it is very
difficult to compare figures on addiction among different authorities in the
literature. However, because this issue is so important to the study at
hand, an attempt will be made here to survey the literature on this subject.
Generally, authors range from those offering personal impressions of the
frequency of addiction to those who give statistics, but none has clearly
defined the criteria for classification of a patient as "addicted". Thus, it
could be argued that assessments of the addictive potential of opioids cited
here reflect primarily the range of physicians’ attitudes on the subject,
rather than "hard data".

There is a wide spectrum of opinion on the addictive potential of
opioids. At one end of the spectrum are those who feel that addiction in
patients with sickle-cell disease is rare indeed. One writer from Great
Britain, for example, Brozovic (1986), maintained that "not one of the 610
Brent, Camberwell, Haringey, and City and Hackney patients with sickle
cell disease is known to be a drug addict" (,07). In fact, this author felt
that

"to suggest that the pain of trunk crisis can be alleviated by
reassurance and paracetamol and that administration of opioid
analgesia leads to drug addiction and dependence pushes us
back to where we were ten years ago when every patient with
sickle cell disease was regarded as either a malingerer or a drug
addict."
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Cole et al (1986) suggest that the withholding of analgesics may
actually encourage addictive behaviors in children:

"Inadequate pain management may ultimately lead the patient
to seek pain relief by other than accepted means, a practice that
could ultimately lead to addiction. Morphine or meperidine
given in the hospital for a period of several days should not and in our experience does not - result in drug dependence."

O
Cole et al note that no "addictive behaviors" were observed in any of their
patients, nor w'ere symptoms of withdrawal.

Other writers express similar views, but with less conviction, as in this
quote from Heller (1988):

"We are reasonably sure that these patients take the [narcotic]
drug only for this purpose [of pain control] and are not
addicted, and we are confident that the drug does not end up
on the street market."

O
This author describes a group of frequent users of the Emergency
Department, around whom the question of addiction appears to arise:

"There are a few patients with such severe pain that they
require Demerol compound, Dilaudid tablets, or other narcotic
drugs. They are known to medical staff, come to the
emergency department at frequent intervals, and are often
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hospitalized, and the risk of addiction can be disregarded in
relationship to the obviously excruciating pain and severity of
their disease".

(m)

The author concludes that "the need for pain relief is stronger than our
fear of addiction."

Other writers express considerably more concern about the addictive
potential of narcotics. For example, Charache (1981) evinces a high
degree of suspicion about drug-seeking behavior:

"Since drug-seeking is learned behavior, the physician must
control the dose and time of administration of narcotics rather
than give the patient the opportunity to seek the drug and have
that behavior rewarded. There are some addicted sicklers; in
my experience they all became addicted outside the hospital,
and most admit they are addicted."

(m)

Charache does not make clear his criteria for addiction, nor does he clarify
the meaning of his remark that patients become addicted "outside the
hospital".

Vichinsky et al are singular in quantitating the risk of opioid
addiction in their patients. In reviewing the records of 101 patients,
apparently both adults and adolescents, for major and minor complications
of narcotic use in sickle-cell disease, the authors uncovered 6 patients who
had seizures from large-dose demerol, 3 suicide attempts (by overdose with

in
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narcotics), 7 cases of "drug dependence" and 3 cases of "drug addiction"
(n3). Of those classified as "drug dependent", none experienced
withdrawal symptoms after counseling and elimination of narcotics. It is
less clear how "drug addiction" was defined (1U). For this reason, it is
uncertain how the authors’ estimate of the prevalence of "drug addiction"
(3%) is to be compared with other studies.

Thus it appears that there is little data on the prevalence of addiction
among patients with sickle-cell disease treated with narcotic analgesics.
More information is available on the issue of addiction in patients with
other illness characterized by pain, for example, chronic pain syndrome, or
systemic illness such as malignancy. As this very broad field, the reader is
referred to other articles on these topics (1,s).

F.

Treatment of sickle-cell disease in the Emergency Department

Treatment of sickle-cell disease in the Emergency Department
presents many challenges. These challenges have been discussed in a
number of articles, three of which will be reviewed in some detail here. In
one article, the type of pain relief given to children and to adults with
sickle-cell disease visiting Emergency Departments is compared. In
addition, two articles describe the authors' experience with the use of
management protocols for treatment of sickle-cell disease in the
Emergency Department.

Vichinsky, 1982, p. 330, table 3
Vichinsky, 1982. p. 330, p.330
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Selbst and Clark, 1990

Selbst and Clark sought to determine whether children with acute,
painful conditions were treated in a similar fashion as adults with similar
conditions. To this end, they examined the treatment of pain in sickle-cell
crisis, lower-extremity fractures, and second- or third-degree burns, in 119
children treated at Children's Hospital of Philadelphia ED, as well as in
162 adults treated for the same conditions at the Medical College of
Pennsylvania ED, over a seven-month period. Charts from these
institutions were assessed retrospectively for patient diagnosis, disposition,
and use of narcotic and nonnarcotic analgesics while in the ED as well as
after discharge from the ED.

Fifty-three of the patients whose charts were reviewed by the authors
had sickle-cell disease, including 27 children (defined as patients under 19)
and 26 adults (defined as patients from 19-65). No patient over 65 years
old had been treated for sickle-cell crisis. Patients with sickle-cell crises
complicated by fever, stroke or other problems were excluded from the
analysis. Analgesics prescribed were almost exclusively narcotic.

Selbst and Clark found that whereas all of the adults with sickle-cell
crisis (26/26) had received pain medications in the ED, only 74% of the
children with sickle-cell crisis (20/27) had received medication for pain,
leaving 7 children who had received no pain medication at all. This
difference in prescription of pain medication in the ED to children and to
adults was significant to P < .05. However, differences in the prescription
of analgesics on discharge from the ED to children was not significantly
different from that to adults. Overall, for all three acute painful
conditions examined by the authors, children received analgesics
significantly less frequently than adults did.
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The authors speculate that reasons for the less frequent prescription
of analgesics to children are varied, and include fear of drug addiction,
concern about respiratory depression, misconceptions about analgesia
needed by children, and the more specific and vehement requests for pain
medication by adults. The authors note that the prevalence of addiction
among their adult patients is unknown, and that physicians’ suspicions
about addiction may have influenced the amount of narcotics they
prescribed (116).

While useful, Selbst and Clark’s study is somewhat limited by its
retrospective nature, and its failure to analyze differences in prescription
patterns between the two institutions, one of which (CHOP) serves
primarily children.

2.

Powers, 1986

Robert Powers has reported on a study of the use of individualized
management protocols for treatment of sickle-cell pain, [n the study,
conducted in the Emergency Department of the University of Virginia
Medical, 5 black men between the ages of 25 and 33 years were identified
as "chronic ED users". These patients were advised that standard ED
management of pain would consist of oral hydration, oxygen, and oral
meperidine or methadone. Parenteral narcotics were given only at the
request of the primary physician, or if the patient required admission for
pain control (l17).

Individualized treatment protocols, developed in concert by a primary
physician and a hematologist responsible for the patient, were kept on
hand in the Emergency Department, along with logs of ED visits. It is
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important to note that the "protocol for pain was begun only after history,
physical examination, and appropriate laboratory testing excluded true
sickle cell crisis, infection, or serious co-existent illness" ("8)

In the year following institution of the program for the five patients,
Powers documented a decrease in the number of ED visits (from 163 to
56), as well as mean length of stay in the ED, percentage of visits given
IM meperidine, and mean dose of IM meperidine. After informal surveys
both of staff and of patients. Powers concluded that the program had been
a success in reducing ED usage, in improving care, and in minimizing
"confrontations between sickle-cell disease patients and professional staff".

The usefulness of Power’s article is somewhat limited by the small
size of his sample (5 patients). In addition, it should be pointed out that
misgivings must arise from Power’s apparent belief that "true sickle cell
crisis" could be excluded by "appropriate laboratory testing" (n9). In fact,
as noted above, exclusion of "true sickle cell crisis" was a precondition for
initiation of the treatment protocol. The implication seems to be that the
protocol was used only on patients with proven drug addiction or drug¬
seeking behavior. Thus it appears that a fundamental misunderstanding of
the limitations of diagnostic testing in sickle cell disease was at the heart of
Power's study.
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Vichinsky, 1982

Another study which examined the effects of a management protocol
for sickle cell disease on utilization of Emergency Department services was
conducted by Vichinsky et al. After doing a survey (described above) of
the prevalence of depression and other psychiatric complaints in sickle-cell
patients, the authors instituted an intensive multidisciplinary treatment
program for patients with sickle-cell disease. The program included
counselling and group therapy, vocational rehabilitation and school tutorial
programs, and a standard protocol for medicating patients in both the
inpatient and outpatient settings.
|

Vichinsky et al identified 10 patients (age range 19 to 41) who "fit
into the chronic pain syndrome category", and examined their utilization of
the Emergency Services and hospitalizations in the 6 months before and in
the 6 months after institution of the program. The authors found a 58%
decrease in Emergency Department visits and a 44% decrease in painrelated hospitalizations. They conclude that their multidisciplinary
approach can "significantly reduce morbidity in sickle cell disease" (12°).

The chief limitation of Vichinsky's data on ED visits is his vague
description of the inclusion criteria for patients. It is unclear how the
"chronic pain syndrome category" is defined. Thus, it is difficult to judge
how such a program would affect ED use by sickle-cell patients in general.
In addition, it is unclear whether the decrease in utilization of emergency
services reflects a decrease in morbidity from the standpoint of the patient.
Nor is it clear whether patients are seeking their care at another
Emergency Department.
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Emergency Department Treatment — an overview

Clearly, research into the treatment of sickle-cell crisis in the
Emergency Department has been relatively sparse. What emerges most
clearly from a number of articles on the subject is a sense of anger and
helplessness, as in this quote from Power’s article:

"Frustration and anger often develop in ED staff as they are
repeatedly confronted with patients demanding narcotics for
relief of pain, which may be unaccompanied by objective signs
of illness."

(m)
The patient with sickle-cell disease who has frequent painful crises
may be considered together with other frequent users of Emergency
Department. These patients, labelled "frequent flyers" in one article
(122), are a source of special frustration for Emergency Department staff.
However, little is known about this small but costly group of patients.
Several studies have shown that frequent visitors to the Emergency
Department tend to have a high incidence of chronic psychiatric
conditions, alcoholism, and recurrent medical problems (123).

Pierce (1990), in a retrospective study of patients in Memphis who
returned to the ED within two days of initial registration, found that
patient-related factors (that is, in which the reason for return was
"primarily the fault of the patient") accounted for 53% of return visits.
Note that in Pierce's study, repeat visits by patients with sickle-cell disease
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were lumped under "illness-related return visits", as an example, like
asthma, of a "recurrence of a chronic disease process" (124), rather than
under "patient-related visits", as drug-seeking and narcotics addiction might
have been.
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Comments on the literature review and its value for the present
study

The literature review above has touched on a number of aspects of
sickle-cell disease which present unique problems for the physician patient
relationship. Not only can painful crisis not be diagnosed on any objective
basis, presently available treatments are merely symptomatic. In fact,
physicians may feel that treatment of sickle-cell disease with narcotic
analgesics may have problematic value at best. To these difficulties on the
side of the physician can be added the painful, disabling and unpredictable
nature of the disease for the patient, which may lead to a variety of
psychosocial difficulties. The interaction between these two groups of
frustrated people - physicians and patients - in the hectic environment of
the Emergency Department has the potential for considerable conflict.

It is against this backdrop that the present study of the physicianpatient relationship at Yale-New Haven Hospital takes place. In
formulating questions to answer in the present study, the literature review
will be an important quide. Among others, questions suggested by the
literature review include the following:

1)

In light of the effects which age and sex appear to have on
psychosocial adjustment in sickle-cell patients, how does
hospital use at Yale-New Haven Hospital differ among sickle¬
cell patients of various ages, and between males and females?

2)

In light of research showing positive effects of strategies such as
management protocols on the care received by very frequent
ED visitors, how many sickle-cell patients visit the YNHH
Emergency Department with high frequency? How do their
illness and their patterns of hospital use differ from those of
less frequent ED visitors?
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In light of research showing varying degrees of tension
surrounding the issues of narcotic dependence and drug-seeking
among patients with sickle-cell disease, how do issues of drug¬
seeking and drug abuse affect the care which patients receive at
Yale-New Haven Hospital?

These questions have formed the basis of the design of the present
study, and will be important in evaluating its results.

Methods Section
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Methods

A.

Methods -- General Introduction

The present study was conducted in three phases. In the first phase
("phase 1"), the goal was to characterize in general utilization of hospital
services at Yale-New Haven Hospital by patients with sickle-cell disease.
To this end, computer records of patient visits to YNHH and the YNHH
ED over the period of one year (October 1, 1989 to October 1, 1990) were
combed for visits by patients with sickle-cell disease, by reference to ICD-9
i

codes and complaint descriptions recorded for each visit. The frequency
of ED visits and admissions could then be examined for various groups of
patients, and breakdowns made by gender, age and frequency of ED visits.
A particular goal of this process was to identify, if possible, a group of
patients with sickle-cell disease with especially high utilization of ED
services.

In the second phase of the study ("phase 2"), telephone interview was
used to gain an understanding of the medical-care experiences of the group
of high-frequency ED users. The interview in each case followed a
standard format, and included both multiple-choice questions and open
questions. Of the 12 patients with sickle-cell disease w7ho used the ED
with the greatest frequency during the study period, 4 could not be reached
for various reasons. The full interview was done with 8 patients, including
the top 6 ED users 19 years and older.
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Phase 1

1.

Phase 1 Data Collection

The methods of the first phase of the present study will he described
first. A computer program was written to examine the hilling records of
YNHH over a one-year period (October 1, 1989 to October 1, 1990), in
order to develope a general picture of the utilization of medical services
by patients with sickle-cell disease.

The data examined in this phase of the study was originally contained
in the general billing data of YNHH. The computer program designed to
study this very large data base examined every "record" of the data base
individually. Therefore, the first task will be to describe how a typical
"record" is added to the data base, and what information it contains.

Each "record" of the data base represents data about an entire visit
which is billable by YNHH (not only those bills which were actually
collected). All the information about a single visit is kept under the same
record. For example, every time a patient visits the YNHH ED, a record
of the visit is generated, which includes basic demographic information
(age, gender, address and phone number etc.), as well as some information
about the visit itself (a short description of the complaint or diagnosis,
eventual disposition, as well as the expenses incurred). After being seen in
the ED, the patient might be discharged from the ED, and the record
would then be closed. If, on the other hand, the patient goes on to be
admitted, information on the admission (including discharge diagnoses,
disposition, and, of course, expenses) is included under the same record.
Thus, for a patient admitted to the hospital from the ED, registration
information about the original ED visit is contained in the same record as
information on the further admission to the hospital.
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Patients who had incurred a hospital bill from any service of the
hospital were identified and included in the patient sample. Expenses
incurred by patients were classified by "source", that is, by the party that
referred the patient for some test, treatment, or admission. The source
might by the Emergency Department, a patient’s private physician, the
Yale Hematology Clinic (which functions as a quasi-independent practice
group of Yale Faculty), or any of a number of institutions, such as nursing
homes or Health Maintenance Organizations. For the purposes of the
present study, the "source" of a given patient visit was classified to be
either "Emergency Department" or "non-Emergency Department".

a.

Operation of the Search Program: First Run

The computer program examined every visit record by all YNHH
patients between October 1st, 1989 and October 1st, 1990. For each
record encountered by the program, two fields of data were examined for
clues that the visit was by a patient with sickle-cell disease, namely, the
"complaint description" and the ICD-9 diagnosis codes. An indication of
sickle-cell disease in either field led the program to copy the record to a
data file. The search criteria for these two fields detail will now be
described in greater detail.

The description of the patient’s complaint, recorded at the patient’s
registration, was searched for an appearance of the words "sickle-cell
crisis", "sickle crisis", "SSD crisis", or any of a number of combinations of
such key words (see appendix for the actual search criteria). It should be
noted that for a number of visits no complaint description was recorded.
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The program also searched the ICD-9 codes recorded for each visit
for the code "282.6" (IJ>), indicating either sickle-cel! disease or Sickle-C
disease (ie double heterozygosity for hemoglobin S and hemoglobin C).
Up to nine ICD-9 codes are assigned to each visit by specially trained
coders in the Office of Professional services of YNHH. It should be noted
that the ICD-9 diagnosis numbers were not infrequently inaccurate, as
seen, for example, in the coding of 282.5, meaning "sickle-cell trait", as a
l

diagnosis for patients with known homozygous sickle-disease. Such records
with miscoded ICD-9 diagnoses would typically be picked up in spite of the
miscoding by their complaint descriptions.
|

The program thus picked up all visits with a complaint description
containing the key words "sickle cell" (etc.) OR with an ICD-9 code
indicating sickle-cell disease. Though this process picked up patients with
sickle-cell disease with what we felt was maximum sensitivity, it also
picked up a number of spurious entries, usually identified by the complaint
description.

For example, the complaint description for one visit might be

recorded as "SS pain crisis”, which proved on inquiry to have referred to
"substernal" pain crisis, or myocardial infarction. These spurious entries
were usually obvious on manual inspection, and were removed.

Undoubtedly, other spurious entries remained undetected in the data
file. One example of a spurious entry which might remain in the data file
would be a visit with no recorded complaint description, and an ICD-9
code mistakenly recorded as indicating sickle-cell disease.

In particular.

N e that the ICD-9 code "282.6" excludes sickle-cell thalasemia and sickle-cell
trait. 282.6 does include the subcodes
282.60 ("sickle-cell anemia, uspecified"),
282.61 ("Hb-S disease without mention of crisis"),
282.62 ("Hb-S disease with mention of crisis"), and
282.63 ("Sickle-cell/Hb-C disease").
However, these subcategories were not completely reliably coded by the Office
of Professional Services, so no further use was made of them.

Methods Section

Page 62

patients with sickle-cell trait might conceivably be expecially likely to
i

mistakenly receive an ICD-d code for sickle-cell disease. The number of
spurious entries is difficult to estimate, but it appears to be very small,
judging from comparisons of the data file with a chart review of a limited
i

number of patients (ie those chosen later for interview). However, time
did not permit confirmation of the validity of the 1033 records by chart
review.

b.

Operation of the search program: second run

There remained an additional source of possible error in the data,
namely, the fact that visits lacking a complaint description (or having, for
example, a misspelling in a key word, such as "sikcle cell disease"), and
also lacking a proper ICD-9 coding for sickle-cell disease, would escape
detection. We could overcome this problem at least for patients who had
been picked up on some other visit, by doing a second run through the
data files.

In this second run, a second computer program (a modification of the
first) searched through all records for the study period. This time,
however, the program searched for all the patients (by unit number) who
had been identified on the first run. This second run ensured that if a
patient had been identified even once throughout the study period, all of
his or her visits to YNHH in that period would be included in the final
data file. Thus, the only visits that escaped detection were by patients who
had been not been identified during any visit during the entire studyperiod.
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It is important to remember that this process of data collection aims
to identify ED visits and hospital admissions by all patients with sickle-cell
disease in the study period, not just incidents of sickle-cell crisis. Although
a large proportion of the visits are likely to be for treatment of sickle-cell
crisis pain, other visits may be for treatment of any number of other
illness, which may or may not be related to sickle-cell disease.
Unfortunately, neither the complaint descriptions for ED visits nor ICD-9
diagnosis codes were recorded accurately enough in hospital billing records
for them to be useful to us in distinguishing crisis pain from other reasons
to seek medical attention.

Another limitation to the process of data collection used here is an
unavoidable selection bias towards patients who seek medical attention for
their disease at YNHH. The data does not include patients in the
community with mild disease, who passed the study year without seeking a
doctor. Other patients may have seen a private physician during the year,
but may not have been hospitalized at or been billed for services at
YNHH. Still other patients may have preferred to travel to other hospitals
to be treated for crisis pain. Because such patients are not included in the
data, the data does not represent a sample of all the patients in the
community with sickle-cell disease.
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"Directly Counted" Variables

The original data file generated as described above contained 1033
records, each one corresponding to a visit to YNHH by a patient with
sickle-cell disease between Oct. 1, 1080 and Oct. 1, 1000. We then counted
the visits made by each patient, using a computer program specially written
in dBase IV programming language. For each patient, the program
counted

1)

total visits

2)

visits to the Emergency Department

3)

total admissions

4)

admissions via the Emergency Department

5)

days spent in the hospital during admissions

In addition, a separate program counted Emergency Department visits and
admissions for each month of the study period.

The data files generated by these counting programs - now with each
record corresponding to a single patient - were then imported into
EXCELL spread sheet format for analysis.

3.

Patient ages

Age was calculated for each patient by subtracting the patient's birth
year from 19%. which was the year into which most of the study period
fell (Oct. 1, 089 to Oct. 1, 1990).

For the purposes of the analysis, a "younger patient" was defined to
be 18 years old of age or younger (ie born in 1972 or later), and an "adult"
was defined to be 19 years of age or older (ie born 1971 or earlier). This
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division of patients into "younger" and "older" patients does not necessarily
reflect whether a patient was treated as a child or as an adult (ie in the
pediatric vs. adult side of the ED, clinics, or inpatient units).

Three children with sickle hemoglobin were born during the study
period, and stayed overnight, thereby accounting for three admissions.
Sickle-cell disease was an incidental finding in these cases (found on
routine screening), and not the reason for admission. These three children
were removed from the data set.
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Phase 2 Methods (interviews with patients)

1.

The patient sample

Interviews with patients were at the heart of the present study. The
group of patients targetted for interview were those sickle-cell patients 19
years and older with the highest utilization of emergency services at YaleNew Haven hospital as identified by the computer survey of hospital visits
by sickle-cell patients in the year-long period between 1 Oct. 1989 and 1
Oct. 1990 (phase 1). Approval by Human Investigations Committee was
obtained before research commenced.

Originally, the 12 patients with the highest number of ED visits in the
study period were chosen to be interviewed. All of them were sent a
letter describing the study, and requesting their participation. Of the 12
patients, 4 could not be contacted:

1 Patient had an unlisted phone

number, and did not visit Hematology Clinic or respond to letters.
Another patient was found to have expired by gunshot in late 1990.
Another patient was dropped from the list when letters to his address were
returned, and no telephone number for the patient could be found. Still
another patient agreed happily to be interviewed, but in spite of many
intervie

appointments and phone calls was never at home with enough

time to be interviewed.

The remaining 8 patients were interviewed in the time period from
January 30, 1991 to March 7, 1991. Of these 8 patients, 2 patients had no
telephone, but were able to be contacted when they visited Hematology
Clinic. Interviews were then arranged with these 2 patients in person.
The other (3 interviews were done by telephone.

The 8 patients interviewed included the 6 most frequent adult visitors
to the ED with sickle-cell disease during the study year. The other 2
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patients were ranked number 10 and number 12 in number of ED visits,
respectively. The 8 patients together accounted for 170 Emergency
Department visits during the study period, or 60% of all ED visits by
adults (age > = 10) during the study period; numbers of ED visits among
them ranged from 6 to 50. Three patients were male, and five were
female.

The average age of the sample was 31.0 years, with ages ranging
from 23 to 41. Two 23-year-old female patients, though in an age group
normally seen by the adult medical service, continued to be seen by the
pediatric service. Because the organization of services to these two
patients was different than it was for patients seen on the adult side of the
ED. they will be considered separately.

2.

The interview format

Patients w’ere interviewed by phone (or if necessary, in person), using
a standard interview format. The format was based originally on the
questions asked in the 1986 National Survey of Access to Health (

).

Considerable changes were made in the original questions as they were
adapted for use with sickle-cell disease patients. The survey questions are
included in the appendix. The average interview duration for the 8
interviews was 57 minutes, with a range of 45 to 70 minutes.

Briefly, the survey asked questions in the following areas.

I 126

1)

Where does the patient receive his or her care?

2)

Experiences with Hematology Clinic

Freeman 1986 Note that no attempt was made to compare the answers to
questions in the present study to corresponding answers to the 1986 survey
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3)

Experiences with the Emergency Department

4)

Experiences as an inpatient

5)

Compliance with doctor's orders

6)

Disability

7)

Pain medication

8)

Access to medical care

9)

General Background, education, marital status

Many of the questions were multiple choice, to allow comparison of
responses by different patients. However, for most of the the sections
there was an open question to record each patient's responses in his or her
own words.
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Results

A.

Phase 1 Results

1.

Introduction to phase 1 results

In this section, results of the computer survey of visits of patients with
Sickle-cell disease to Yale-New Haven from Oct. 1,1989 to Oct. 1,1990 will be
presented. The results will be organized to answer the following questions:

1)

Who were the the patients with sickle-cell disease seen at YaleNew Haven Hospital?

What what was their overall distribution

in terms of age and gender?

2)

How much did sickle-cell patients use hospital services in toto?

3)

How did hospital use differ for patients of different age groups
and between males and females?

4)

How did hospital use differ for patients with various levels of
utilization of ED services? In particular, what patterns of hospital
use can be found among patients with sickle-cell disease who
frequently visit the Emergency Department?

5)

Do visits to the Emergency Department follow cyclical patterns
over time?

Especially, does the frequency of visits vary with

temperature or season?

If so, are these patterns different for

young patients than for older patients?

These questions will be answered by reference to 10 charts, which will
be provided in the succeeding pages.

For more exact numbers, the reader
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may turn to the 7 tables of the results, placed next to the corresponding
charts.

An overview of the sample of patients with sickle-cell
disease

See tables 1 and 2, and charts 1 and 2

A total of 132 patients with sickle-cell disease were identified.

They

had a mean age of 21 years. 48 were male, and 84 were female.

Patients visited the Emergency Department a total of 422 times during
the study year. This represented an average of 3.2 visits per patient per year.
Patients in the sample were admitted a total of 164 times, and they spent a
total of 969 days admitted in the hospital. Admissions lasted a mean average
of 5.9 days long.

Of the 422 visits to the Emergency Department. 131 (31.0%) resulted
in admission. Of the 164 admissions, 131 (79.9%) were via the Emergency
Department.
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3. Analysis of results by gender and age

See tables 1 through 4, and charts 1 through 4

Chart number 1 shows a breakdown of hospital use by age groups. As
these data demonstrate, sickle-cell patients seen at Yale are predominantly
young.

Of the 132 patients, 33 (25%) were 10 years or younger, and 33

(25%) were between 11 and 20. Thus, of all the patients seen. 50% were in
the first two decades of life.

The 21-to-30 age group was the largest, with 35 patients (27% of the
total number).

But in age groups older than this, numbers fell off sharply.

Only 21 patients (15% of the total number) were in the 31-to-40 year group,
and 6 patients (5% of total) were in the 41-50 age group. Only 4 patients in
the sample were older than 51 years.

Visits to the Emergency Department varied widely among different age
groups.

By far the greatest proportion of ED visits was accounted for by

members of the 21-30 year age group.

Patients between 21 and 30 years

accounted for 37.9%) of all ED visits, out of proportion to their numbers
(26.5% of total) (127).

As graph 1 shows, patients in successive age groups

to "either side" of the 21-30 year age group visited the ED proportionately
less and less.

Chart 1 demonstrates a similar peak in the numbers of admissions and
hospital days for various age groups; this time, however, the peak lies in the
11-20-year age group. Patients in this group were admitted 47 times (32% of

127

It is of note that the 3 patients who visited the ER with the greatest frequency
were all over 30 years old. Thus, the peak of ER visits in this age group is not
simply due to skewing by the 3 top ER visitors.
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total) and spent 312 days in the hospital (32% of total), somewhat out of
proportion to their numbers (25% of total).

There was a striking predominance of females in the sample (See charts
2,3 and 4). Of 132 patients in the total sample, 84 (64%) were female, and
48 (36%) were male. These gender proportions were similar both for patients
18 years and younger and for patients 19 years and older.

Use of emergency services by patients with sickle-cell disease at YaleNew Haven Hospital differed somewhat by gender. As chart 2 shows, female
patients, partly reflecting their greater numbers in the sample, predominated
overall in total visits to the ED, with 56% of ED visits by females, and 43.1%
by men. However, actual "per patient" visits to the ED were slightly higher
for men (3.8 ED visits/patient) than for women (2.9 ED visits/pt).

Among patients 18 years and younger (table/chart 3), the predominance
of total ED visits by females was much more striking, with 84% of ED visits
by females, and 16% by males. Among these younger patients, "per person"
visits to the ED were higher for women (2.5 ED visits per patient) than for
men (1.0 ED visits per patient).

Among all patients 19 years or older (table/chart 4), however, the
female dominance of ED use was reversed, with males accounting for 54.6%
of ED visits, and females for 45.4%.

On a "per person" basis, the gender

difference was even more striking, with 5.8 ED visits per male patient, versus
3.2 ED visits per patient for females.

Care

must

be

taken

in

assessing the

importance of this

male

predominance in ED use by sickle-cell patients 19 years and older. In fact,
this male predominance appears on closer examination to be at least partially
due to a skewing effect by a very small group of patients with very high
frequency of ED use. When, for example, the three patients with the highest
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frequency of ED use (two males and a female, accounting together for 119
ED visits) were temporarily removed from the data set, female predominance
in use of the ED reappeared (see chart 4a).

In numbers of admissions and hospital days for all patients, female
patients predominated as well, again at least partially reflecting their larger
numbers in the sample (see table/chart 2). Female patients overall accounted
for 72.6% of all admissions for sickle-cell patients, and 72.5% of hospital
days, versus 27.4% of admissions and 27.6% of hospital days for males.
Morover, on a "per patient" basis overall, female patients were admitted more
frequently (1.42 ad 'its/patient) than males (.94 admits/patient). However,
average

length

of

hospital

stay

was

similar

overall

for

men

(5.9

days/admission) and women (5.9 days/admission).

In summary, the sample of sickle-cell patients included 132 patients with
a mean age of 21 years.

There was a striking predominance of young

patients, with 50% of patients under 20 years of age, and only 4 patients over
the age of 50 years. Of all hospital use by members of the sample, the largest
proportion of ED visits was accounted for by patients in the 21-30-year age
group, and the largest proportion of admissions and hospital days was
accounted for by patients in the 11-20-year age group. In addition, there was
a striking predominance of female patients in the sample, with females
making up 64% of the sample overall. Female patients overall accounted for
57% of ED visits, 73% of total admissions, and 72% of total hospital days.
The female predominance in patient numbers and in hospital use was greater
in younger patients than in older patients.

f
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Analysis of results by number of ED visits

See tables 5 and 6, and charts 5 and 6

The variation in frequency of use of emergency services among sickle¬
cell patients in the sample was very wide. It was observed at the outset that
a small number of patients had visited the ED with very high frequency. For
example, the five adult patients with the highest ED use had visited the ED
50 times, 37 times, 32 times, 22 times, and 15 times respectively during the
study year.

Many other patients had visited only once or twice during the

study year, or not at all.

In order to study overall hospital use by patients with different levels
of use of emergency services, the sample of sickle-cell patients (132 patients)
was stratified into four groups based on number of ED visits during the study
year. The groups were arbitrarily defined as follows:

Group 1: No ED visits at all
Group 2: Between 1 and 5 ED visits
Group 3: Between 6 and 10 ED visits
Group 4

11 or more ED visits

!

Data were analyzed separately for younger patients and adult patients.
It is important to note that this division, as well, is based on an arbitrary
choice, namely, on the choice of 18/19 years of age as the dividing point.
This division is convenient for the sake of analysis, and offers a simple way
to ascertain whether the patterns of hospital use are grossly different for
children and for adults with sickle-cell disease.

However, this division may

not, for example, reflect whether patients in each group are seen on the
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pediatric or on the adult side of the ED.

As will be seen, a number of

patients in their early 20’s continued to be cared for by the pediatric service.

The following chart summarizes data on ED visits (for more detail see
tables 5 and 6):

Visits to the Emergency Department by Patients at Yale-New Haven
Hospital from October 1, 1989 to October 1,1990:

Group 1

Younger Patients

Adult Patients

(age < = 18 vr)

(age > = 19 yr)

Pt.

ED visits

Pt.

ED visits

#

#

(%)

#

#

23

0

(0%)

19

0

(0%)

33

62

(50%)

38

81

(27%)

4

30

(24%)

8

60

(20%)

2

33

(26%)

5

156

(53%)

62

125

(100%)

70

297

(100%)

(%)

(no ED visits)

Group 2
(1-5 ED visits)

Group 3
(6-10 ED visits)

Group 4
(11+ ED visits)

TOTALS
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Younger patients (18 years and younger)

Among the 62 sickle-cell patients who were

18 or younger (see

table/chart 5) during the study year, the majority (33 patients) had between
1 and 5 ED visits, 4 patients had between 6 and 10 visits, and only 2 patients
had 11 or more visits. The greatest number of visits in this group was by a
2-vear old female patient, who visited the ED 21 times during the study year.

Younger patients in groups and 3 and 4, as was expected from the group
selection criteria, accounted for ED visits out of proportion to their number.
The 6 patients in these two groups (about 10% of the total group of younger
patients) accounted together for 63 visits (about 50% of all ED visits by
younger patients).

Younger patients who visited the ED frequently were also hospitalized
more often, and stayed in the hospital a greater number of total days, than
patients who visited the ED less frequently. Patients in groups 3 and 4 were
admitted an average of 4.8 and 6.5 times per patient, respectively, compared
with .3 times per patient among patients in group 1, and 1.2 times per patient
in group 2.

However, average length of hospital stay (as shown in table 5,

left-most column) was relatively similar for all groups, with an average of 5.1
days per admission.
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Adult Patients (19 years and older)

Among the 70 sickle-cell patients who were 19 or older (see table/chart
6) during the study year, 19 patients did not visit the ED at all, 38 patients
visited between 1 and 5 times,

8 visited between 6 and 10 times, and 5

patients visited 11 or more times. The greatest number of visits by an adult
was by a 30-year old male, who visited the ED 50 times during the study year.

Adult patients in groups 3 and 4 (ie with 6 or more ED visits) visited
the ED far out of proportion to their numbers. The 13 patients in these two
groups (representing about 19% of adults in the sample) accounted for 216
ED visits, or about 73% of all ED visits by adults. In fact, the 5 patients in
group 4 alone, though representing only 7% of adult patients, accounted for
about 53% of all ED visits by adults.

As with younger patients, adult patients who visited the ED more
frequently were also hospitalized more often, and stayed in the hospital a
greater number of days, than patients who visited the ED less often. Adult
patients in groups 3 and 4 were admitted an average of 3.3 and 3.4 times per
patient, respectively, compared with .4 times per patient among patients in
group 1, and .9 times per patient among patients in group 2.

Average length of hospital stay for all adult sickle-cell patients (as
shown in table 6, left-most column) was 6.6 days per admission. Patients in
group 1 (ie patients who had not visited the ED, and thus who were not
admitted via the ED) had an especially high average length of hospital stay,
at 10.5 days per admission. Conversely, patients in group 4 (ie those with at
least 11 visits) had a relatively shorter length of hospital stay, at 4.8 days per
admission.
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Summary of data on frequent ED visitors

In summary, the most striking common theme among both younger
patients and adults was the disproportionate number of total ED visits
accounted for by small groups of very frequent ED visitors. Among patients
in groups 3 and 4 (ie those with 6 or more ED visits), 6 younger patients
(10% of all younger patients) accounted for 50% of all ED visits by younger
patients, whereas 13 adult patients (19% of all adult patients) accounted for
73% of ED visits by adults.
Note that this predominance of ED use by a small group of frequent
ED users w'as much more marked in adults than in younger patients. Indeed,
among adult patients, those patients with 6 or more ED visits were greater
in number (13 adult patients vs. 6 younger patients) and accounted for a
higher proportion of total ED use (73% of visits by adults vs. 50% of visits
by younger patients).

Among both younger patients and adults, patients who visited the ED
frequently were also admitted more frequently on average, and spent more
days in the hospital, than patients who visited the ED less frequently.

5.

Analysis of results by month

See table 7, and charts 7 through 10

It has been often reported that sickle-cell crisis may be evoked in many
patients by cold weather, or by rapid changes in temperature. One might thus
expect that during cold weather that visits to the ED by sickle-cell patients
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would increase, or that patients would he admitted more frequently.
Therefore, it was of interest to investigate seasonal variations in hospital use.

To this end, numbers of ED visits and admissions were calculated for
each month of the study period, for the group as a whole, as well as for
younger patients (18 years and younger) and for older patients (19 years and
older).

These were plotted against average daily temperatures for each

month, as reported by the United Illuminating Company, a local electric
utility company. The results may be found in table 7 and charts 7 through 10.

The number of Emergency Department visits and admissions varied
widely by month. Monthly ED visits during the study period ranged from 19
to 47 visits, with a mean average of 35.2 ED visits/month.

Monthly

admissions

of

ranged

from

7

to

20,

with

a

mean

average

13.7

admissions/month.

In

order

to

evaluate

these

monthly

fluctuations

in

Emergency

Department visits and admissions, numbers of ED visits and admissions were
totalled for the four months during the study period when average daily
temperatures were under 40 degrees F (December, January, February, and
March), and also for the four months when average daily temperatures were
above 60 degrees F (June, July, August and September).

Put briefly, no increases in Emergency Department visits were found
during colder months of the 1-year study period. As can be seen in table 7,
numbers of ED visits and admissions were very similar for cold and warm
months. For all patients, in fact, ED visits during the four "cold" months (142
ED visits) were actually slightly fewer than in the four "warm" months (150
ED visits). Numbers of admissions for all patients were also similar during
"cold" months (60 admissions) and "warm" months (58 admissions).
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Neither was a seasonal variation in hospital use seen among younger
patients as group (see table 7, chart 8), nor adult patients as a group (table
7. chart 9). Numbers of Emergency Department visits and admissions were
similar during warm and cold months for both younger and adult patients.
The only case in which a cyclical pattern appears to exist, as seen visually in
a rising and falling curve, is in admissions for younger patients over the study
year, with a nadir in a warm month (May) and a peak in a cold month
(December) (see chart 9).

But as remarked, no significant difference was

found in younger patients’ total admissions over the 4 "cold" and the 4 "warm"
months.

It should be remarked here that the method followed here only roughly
examines the effect of temperature on sickle crisis. Figures were totalled by
month, and no attempt was made to quantify the increased risk of sickle crisis
based on the temperature during any individual day, or any time of day.

In summary, there was wide variation in numbers of Emergency
Department visit and admissions by month during the study period. However,
no cyclical or seasonal pattern could be observed, neither in sickle-cell
patients as a whole, nor in younger patients nor adult patients as groups. The
present analysis indicates that total ED visits and admissions among sickle-cell
patients did not increase during cold months.
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Summary of computer survey results

Visits to YNHH hv patients with sickle-cell disease. 1
Oct. 1898 to 1 Oct. 1990

The computer survey identified a total of 132 patients with sickle-cell
disease, with a mean age of 21 years.

Of the 422 visits to the Emergency

Department accounted for by sickle-cell patients during the study year, 131
(31.0%) resulted in admission. These 131 ED admissions represented 79.9%
of the 164 total admissions for the group.

Admissions overall lasted an

average of 5.9 days each.

Results of the computer survey were analyzed by age, gender, and
frequency of ED visits, as well as by month. The following findings were
especially striking:

a. )

There was a striking predominance of young patients,
with 50% of patients under 20 years of age, and only
4 patients over the age of 50 years.

b. )

There was a striking predominance of female patients
in the sample, with females making up 64% of the
sample overall. Female patients overall accounted for
57% of ED visits, 73% of total admissions, and 72% of
total hospital days.

The female predominance in

patient numbers and in hospital use was greater in
younger patients than in older patients.
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The most striking common theme among both younger
patients and adults was the disproportionate number of
total ED visits accounted for by small groups of very
frequent ED visitors. Among patients with 6 or more
ED visits during the study year, 6 younger patients
(10% of all younger patients) accounted for 50% of all
ED visits by younger patients, whereas

13 adult

patients (19% of all adult patients) accounted for 73%
of ED visits by adults.

d. )

Among both younger patients and adults, patients who
visited the ED frequently were also admitted more
frequently on average, and spent more days in the
hospital,

than

patients

who visited

the

ED

less

frequently.

e. )

There was wide variation in numbers of Emergency
Department visit and admissions by month during the
study period. However, no cyclical or seasonal pattern
could be observed, neither in sickle-cell patients as a
whole, nor in younger patients or adult patients as
groups.
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Tables and charts - phase 1

TABLE I (CORRESPONDS TO CHART I)

BREAKDOWN RY ACE GROUPS

DT Fleming

SICKLE CEU, PATIENTS SEEN AT YALE NEW HAVEN HOSPITAL FROM OCT I 1989 TO OCT 1.1990

Douglas T Fleming. YMS
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CHART NUMBER 2
HOSPITAL USE BY ALL SICKLE CELL PATIENTS
OCT I. 1989 TO OCT 1. 1990 AT YNIIH
BROKEN DOWN BY LENDER
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Phase 2 results

1.)

Where does the patient receive his or her care?

All 8 of the interviewed patients stated that Yale-New Haven Hospital
was the place they usually went when they wanted to see a doctor about their
sickle-cell disease (02). When asked whom they would call first in the event
of a sickle-cell crisis (03), all 8 patients replied that they would call the
hematologist they knew from a Yale Hematology Clinic; 6 of the patients
attended adult hematology clinic, and 2 attended pediatric hematology clinic.

Four of the adult patients had been seen at other health-care facilities
in the past year (05): two patients had sought treatment in the Emergency
Department of a nearby community hospital in New Haven, 3 times and 1
time respectively. In addition, two other patients had been out of state in the
past year during a sickle-cell crisis, and had been hospitalized out of state,
one time each. However, none of the patients had seen a private physician
(that is, one with his or her own office outside a hospital) in the past year
(06).

2.)

Patient satisfaction with overall care

Patients were asked to evaluate the care they received in three areas of
Yale-New

Haven

Hospital,

the

Hematology

Clinics,

the

Emergency

Department, and the inpatient floors of the hospital (ie while admitted). For
each of these three areas, patients were asked to give a rating in three topics:

1)

"In general, how well do the doctors ... explain to you what is
going on with you medically?"

Results Section
2)

Page 85

"In general, how well do doctors ... do as far as taking enough
time to see you?"

3)

"In general, how well do doctors ... do at treating the pain of your
sickle-cell crises?"

Patients were asked to give a rating in each of these topics from among
the following choices:

1) Poor, 2) Fair, 3) Good and 4) Excellent. In order

to facilitate comparison of patients’ responses in different hospital areas,
grades of "excellent" were recorded as a score of "4", "good" as a score of "3"
and so on. A response of "fair to good" was recorded as "2.5". In addition to
the answers to individual questions, a combined score was calculated by
adding together the ratings in the three topics, and then dividing by 3. Thus,
the combined scores had the same possible range as the answers to individual
questions, ie from 1 to 4.

Mean scores in the three topics for the 6 patients treated on the adult
side of the Clinics, Emergency Department and inpatient floors were as
follows, with standard deviations shown in parentheses ():
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Hospital areas:

Topics:

Clinic

1) Explaining:

3.2 (0.8)

2.2 (1.0)

3.5 (0.5)

3.0 (0.8)

2.2 (0.8)

3.3 (0.8)

ED

Inpatient floors

2) Taking
enough time:

3) Treating
pain crisis:

4) Combined score

3.3 (0.6)

3.1 (0.5)

2.2 (0.8)

3.7 (0.5)

2.2 (0.6)

3.5 (0.5)

Because the sample size (6) was small, and there was no reason to
expect that the variances of the scores in the three areas (Clinic, ED and
admissions) would be different, the Student’s T-test was used to compare
average scores by the 6 patients treated as adults.

Patient's scores of quality of patient care in all areas were significantly
lower for the Emergency Department than they were for the clinic or for the
floors.

As regards "treating pain crisis", for example, the ED received

significantly lower ratings than the clinic (P<.05) and the inpatient floors
(P<.005). Overall scores were also significantly lower for the ED than for
the clinic (P<.()25) and the inpatient floors (P<.005). Differences in scores
between the clinic and the floors were not statistically significant.

It can be concluded that patients treated on the adult side of the
hospital were significantly dissatisfied with the care they received in the
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Emergency Department compared with the clinics and the floors.

Overall

score for the ED was 2.2, which was closest to "fair". Care in the clinics and
inpatient areas received higher ratings of 3.1 and 3.5 respectively, which
translate to between "good" and "excellent".

With only 2 patients in the sample treated on the pediatric side, it is
difficult to come to any general conclusions regarding pediatric care.
However, it is worth noting that both patients gave for the most part scores
of 4 ("excellent") to the clinics, ED, and floors equally.

Patients' experiences in three areas of the hospital - clinics, ED and
inpatient -- will now be discussed separately.

3.)

Experiences with Hematology Clinic

All six sample patients treated on the adult side of the hospital reported
generally good long-term relationships with their clinic doctors at the Adult
Hematology Clinic. Relationships with attending doctors were often of very
long duration; in fact, one patient had been seeing her clinic attending for
some decades. Four of the six patients had seen their clinic attending for 5
or more years.

The shortest relationship was 2 years.

Five out of the six

patients gave their clinic attending a rating of "good" or "excellent" in
"understanding their medical problems" (128).

In spite of these generally good ratings, 4 out of the 6 patients reported
that they had had problems obtaining prescriptions at clinic in the past year.
One of these patients reported that clinic doctors had been prescribing

Unfortunately, no question specifically addressed the differences in patients’
perceptions of their attending physicians and of the hematology fellows, who
also worked in clinic.
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generic meperidine instead of the proprietary Demerol, and that the generic
version did not relieve pain to the same degree. The patient ascribed this
change to financial reasons:

"My doctors at clinic say that Demerol is too

expensive, and that my medical care [Title 19] won’t cover it".

The other three patients who reported difficulty in obtaining pain
medications felt that suspicions of drug-seeking or drug addiction were the
source of the difficulty.

In several instances, patients acknowledged having

had actual problems around the issues of narcotics in the past, as in this
quote:

"If I’m going through a crisis, it can last 4 to 5 days. They used to
give me 20 Demerol [tablets], and I’d have a few extra. So I’d sell
them to another patient with sickle-cell disease. I was honest with
my doctors at clinic - I told [my doctor] myself, but they held it
against me."

However, regarding the issue of addiction, the same patient noted that "when
you’re in pain, you just need something to help you - that’s not addiction.
They [doctors] have never understood the pain, or experienced it."

More commonly, patients who experienced difficulty obtaining pain
medications at clinic felt that they were encountering the suspicions generated
by other patients, who had abused or sold their pam medications.

For

example, one patient remarked that

"When I first came to clinic, they [the doctors] thought I was one
of those people who sell their meds.

Once they realized that I

wasn’t one of those people, everything was OK.'

Similar echoes can be heard in this remark by another patient:
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"At first it was definitely slack - it was a problem of people
abusing pain killers, so the clinic doctors were real tight about
giving pain killers.

Now it’s gotten better, at least for me.

But

other patients are still having problems."

Thus, these patients felt that establishing a trusting relationship with a
physician in clinic was possible even if it was made difficult by the presence
of other patients who abused pain medications.

One patient described an occasion when he had difficulty obtaining pain
medications early in the course of a sickle crisis which later was complicated
by a serious infection:

"At first, [my doctor] didn’t believe that the pain was so bad. He
didn't want to give a lot -- this way he remained closer in contact.
In the end, he was fair."

Thus, the physician’s reluctance to give prescriptions for large amounts of
pain medications seemed reasonable to the patient, as a way to stay "closer
in contact".

It was possible to have the opposite problem as well, as one patient put
it:

"Clinic doctors don’t hesitate to prescribe narcotics. There’s no
hesitation — sometimes they even push the Demerol on me when
I feel I don’t need it."

Patients had a number of suggestions on how they felt clinic should be
improved: for example, one patient felt doctors in clinic should not stick too
inflexibly to "certain protocols they have for pain ... there are times when
they should be more lenient, when a patient really needs it'.

Also, the
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doctors should not be "so hurried". One patient remarked on the very long
wait before a patient could be seen: "When you come to clinic, you have to
wait and wait and wait for a doctor to see you.

When you’re in pain, the

waiting is the hard part."

Overall, patients were generally positive about the care they received
in adult clinic.

As one patient remarked. "Overall, they’re pretty good, the

doctors I deal with. I like my attending doctor too."

The two patients treated in the pediatric hematology clinic gave glowing
reports, such as this one:

"They are excellent at clinic - when I call, they get everything
ready for me, my fluid bags and my medications.

They even

arrange everything for me when I go to the ER. They really know
me and understand my problems."

Of course, no generalizations can be made about pediatric clinic due to the
small sample size.

4.)

Experiences with the Emergency Department

Interviews with six patients who were frequent visitors to the adult side
of the Emergency Department during the study period revealed considerable
conflict and anger around issues of pain relief and narcotic analgesics.

In

addition, patients remarked that they often felt neglected or forgotten in the
hectic atmosphere of the Emergency Department. All six patients reported
that there was no doctor at the Emergency Department who was responsible
for their care on an extended basis, from visit to visit.
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Difficulty obtaining sufficient analgesia

When asked whether they had had any difficulty obtaining sufficient
painkiller during visits to the ED in the last year, 5 out of the 6 patients
replied that they had, and that the reason had been that "doctors did not
believe that the patient needed more painkiller" (0.20). The frequency of
this problem was described as "very often" by 3 patients, "fairly often" by 1
patient, and "only seldom" bv 1 patient. Interestingly, the 3 sickle-cell patients
who answered that they had had difficulty obtaining painkiller "very often"
were also the same sickle-cell patients who had visited the ED with the
greatest frequency during the study period.

b.)

Common themes in the interviews with adult patients

(1)

Incomprehension of sickle pain

A number of common themes were brought up by patients in the
interviews. Perhaps the most common was the feeling (cited by 4/6 patients)
that there was little comprehension of the severity of sickle-cell pain among
Emergency Department staff. In a particularly illustrative quote, one patient
asked

"How can the ER doctors know when someone isn’t in pain?
Thev don’t understand how much pain sickle-cell patients have."

In another example, a patient remarked that

"...sometimes the doctors tell you, ’the pain in your wrists isn’t so
bad — go home and take some Tylenol.' But I say, ’if I could take
some Tylenol at home, why would I come in here?’.
makes me mad sometimes."

It really
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Thus, the patient was angry that appearing in the ED for pain relief was
apparently not assumed by ED staff to be sufficient evidence that the pain
could not be handled at home with non-narcotic medications. This feeling
was echoed by another patient who had had difficulty obtaining sufficient
pain relief: "I wouldn’t go to the ED if I wasn’t in pain."

(2)

Accusations of drug-seeking and malingering

Patients frequently reported that they felt accused of drug-seeking, drug
abuse, or malingering by ED staff (5/6 patients). As one patient put it, "they
look at you like you're some kind of junkie". The accusation of drug abuse
could take direct or indirect forms. As an example of a direct accusation, one
patient noted that "one time a nurse made a smart remark - she said I was
on drugs, and that I had overdosed [before]". Another patient described a
direct accusation of drug abuse as follows:

"They treat you like dirt if they think you’re injecting drugs. They
accused me of shooting up and carrying drugs on me. I thought,
now it’s going to be hell getting treated. After that, they gave me
only one shot [of Demerol], and I couldn’t get a hold of my
hematologist for more."

Thus, the patient felt that the accusation of drug abuse was directly connected
to the withholding of narcotic analgesics. Note that the patient looked to his
hematologist, that is, to his primary physician from hematology clinic, for help
in obtaining treatment with narcotic analgesics.

Indirect accusations of drug-seeking were also described by several
patients, and appeared to be more subtle. One patient described this type of
interaction as follows:
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"People tell you that you’re abusing drugs in a very indirect way - they’ll just hint around the issue for a while. Or they’ll tell you
about other people who abuse drugs, and make you feel like
you're being lumped in with them."

Patients generally were quite taken aback by the accusation of drug¬
seeking, which they found to be unwarrented.

For example, one patient

remarked that Tve even been insinuated as being a drug user — no one in
the ED knows me or cares".

This same patient reported that it had been

necessary to get a "letter of reference" from a hematology fellow attesting to
the patient’s honesty and documenting the doses of Demerol previously
needed to treat a crisis.

Several patients (2/6 patients), however, suggested that doctors were
justified in some cases in being "careful" about analgesics, as in this remark:
"Of course, they [the doctors] do try to cut down on painkillers, with all the
abuse of painkillers going on". Another patient made a very similar remark:
"There are some people who sell prescriptions, so doctors have to be very
careful."

Two patients admitted to having had actual problems with drug use in
the past.

One patient had once attempted to self-medicate sickle pain by-

injecting a crushed Demerol tablet, and subsequently had a seizure on the
way to the Emergency Department. Another patient had used "drugs" in an
unspecified manner some 4 to 5 years previously, but stated that drug use had
stopped.

Both patients maintained that though they were not abusing

narcotics presently, they felt that lingering suspicions raised by these previous
incidents continued to obstruct their access to narcotic analgesics.
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In a particularly interesting comment, one patient described the mode
by which suspicions about drug-seeking were passed among physicians in the
Emergency Department:

"Some ER doctors treat you well. For others, some nurse will tell
them something about me which changes their attitude completely
-- a nurse might say, I saw him last week, and I don’t think he’s
really sick’... Attitudes about me get passed from doctor to doctor,
so that there are times when no one believes me when I need
more painkiller.

And then I might not be able to reach my

hematologist, and can’t get the relief I need, and it feels like I’m
banging my head against the wall."

Thus the patient felt unable to escape previously aroused suspicions about
drug-seeking, even when being treated for the first time by a new physician.

(3)

Issues of power and control

Another important theme which emerged from several of the interviews
(2/6) was the theme of power relations between physician and patient. One
patient, for example, made the following remark:

'There's one female doctor there [at the ED] who feels that she
decides how much painkiller I get - other people will ask me how
much I need, but not her".

Thus, for the patient, the interaction between the patient and the physician
in this case was centered around the control of medications.

In another

example, a patient who had had difficulty with substance abuse several years
previously felt that pain medication was being withheld in a punitive fashion:
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"I need like 125 mg of Demerol and 50 of Vistaril [when I have
a crisis].

When they won’t give me as much as I need, they’re

punishing me - I’m there for my condition... They look at me like
they’re thinking, ’you just want the drugs’".

This feeling of helplessness and punishment was echoed by another patient,
who stated, "when they [the doctors] get you in a spot, they can really drive
the pain in."

(4)

Toradol

Two patients specifically mentioned the use of Toradol (generic name
Keterolac), a non-steroidal anti-inflammatory medication.

One patient

reported that it had been tried twice, but had not been effective:

"it just burned and made me sick in my stomach. I think they [the
doctors] should have explained to us about it before experimenting
on us."

In the case of another patient, the patient believed on one occasion that
keterolac had been secretly substituted for meperidine, as the patient noticed
no effect from the injection given.

In addition, the patient was suspicious

because the nurse had not gone to the narcotics room for medication prior to
the injection. Thus, both patients who reported being treated with keterolac
felt that this medication was ineffective, and that it was used in a deceptive
fashion in their cases.
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It should be noted that an extensive literature search revealed no study
which documented the effectiveness of keterolac in sickle-cell disease.

c.)

Interviews with 2 patients treated by the pediatric
service of the Emergency Department

Only two of the patients who were interviewed had been treated on the
pediatric side of the Emergency Department. Both of these patients were 23
years old, and would normally have been triaged to the adult medical service.
However, they continued to be treated by the pediatric service, where they
had been seen fo, many years by a special sickle-cell service overseen by
pediatricians and coordinated by a nurse-practitioner.

Both expressed

reluctance to be transferred to the adult service because of the rushed
atmosphere they perceived to exist there, as in this quote:

"[My nurse] has told me that soon I’ll have to go over to the adult
ER - but the patients on the adult side don’t get the same
treatment. The doctors over there don’t know me, and they rush
you through and don’t give you the same attention as on the
pediatric side."

Both patients seen by the pediatric service, therefore, were aware that their
age made it more and more difficult to be retained by the pediatric service
in the Emergency Department, but persisted in their attempts to avoid what
they perceived to be a hectic atmosphere on the adult service.
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Overall impression of patients' experiences with the
Emergency Department

The overall impression left by the 6 interviews with patients treated by
the adult service of the Emergency Department was one of distrust and
anger.

These patients, who had all visited the Emergency Department

frequently for sickle-cell crisis, felt that suspicions of drug-seeking directed
against sickle-cell patients were prevalent (though not universal) among their
physicians in the ED, and that this distrust, transmitted among physicians and
nurses, made it difficult to receive sufficient narcotic analgesics.

It is

interesting to note that the two patients who were treated by the pediatric
service were of an age normally treated by the adult service; both expressed
reluctance to be transferred to the adult service because of the rushed
atmosphere and lack of personal attention they perceived to exist on the adult
service.

It must be understood that whatever basis ED staff had for their
suspicions of drug-seeking, it could not be argued that frequent visitors to the
ED did not suffer from very debilitating, serious illness.

In fact, the eight

patients interviewed were admitted to the hospital relatively frequently
throughout the study year (an average of 3.6 times per patient). In addition,
all eight patients had had at least two serious complications of sickle-cell
disease in previous years.

Among the eight patients, these complications

included transient ischemic attacks or cerebrovascular accidents, pneumonias
or pulmonary infarcts, cholelithiasis, hepatitis B, priapism, cardiac dilatation,
ischemic heart disease,

bony infarcts,

pulmonary

embolism, vertebral

osteomyelitis, aplastic crisis, iron overload and transfusion resistance.
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Experiences on inpatient floors

The 6 patients who were hospitalized as inpatients on the adult medical
service during the study period reported generally positive experiences. As
noted above, patients treated on the adult service gave the inpatient floors a
combined rating of 3.5, which translates to "good to excellent".

Only 2

patients reported having had any difficulty obtaining sufficient pain relief, and
both of these patients stated that this problem had occurred only "seldomly".
One recurrent problem, reported by 2 patients, was that the waiting time in
the Emergency Department before transfer to an inpatient floor could be
extended, as long as 3 to 4 hours.

Once on the inpatient floors, however,

patients were generally satisfied with their care.

Two patients were hospitalized as inpatients on the pediatric service.
Both were satisfied with the care they received, and neither reported any
difficulty obtaining adequate pain relief for sickle crisis while admitted.

6.)

Compliance with doctor's orders

Of the 8 patients interviewed, seven reported that they had been
advised by their physicians to cut down on activities such as sports and heavy
work, and all 8 reported that they had been advised to drink large quantities
of water and to take other steps to avoid sickle crisis.

As reported by

patients, compliance was good, with all 8 patients stating that they tollowed
their physician’s advice either "always" (5 patients) or "usually" (3 patients).

Results Section

Page 99

Two patients noted that they occasionally played sports or participated
in other strenuous activities against which they had advised by their
physicians, but that playing sports helped them to stay fit and remain "like a
normal person".

Their decision to participate in strenuous activities was a

personal one, and they did not express any conflict with their physicians over
it. As one patient put it,

"I felt that sports helped me, even if it brought on a crisis
sometimes -- I try to stay active. Strenuous work causes crisis, so
1 follow doctor’s orders not to do it."

What was notable, therefore, in patients’ answers to questions about
compliance was that there was little conflict with their physicians over steps
to be taken to avoid sickle crisis. Steps such as drinking large quantities of
water and avoiding strenuous effort, though burdensome at times, were
generally seen by patients as reasonable.

7.)

Disability

Of the 8 patients interviewed, all reported that sickle-cell disease had
had a profound effect on their lives. The effects of the disease were greatest
on patients’ ability to earn a livelihood; all 8 patients reported

that they

would have liked to "work at a job or business" in the previous year, but that
sickle-cell disease had prevented them from doing so at some time. Patients
described the impact of the disease on their ability to work at a job or
business as "very large" (7 patients) or "large" (1 patient). Of the 8 patients,
5 were on disability, one was "temporarily out of work', one was not usually
employed", and one worked part time.

Results Section

Page 100

Effects of the disease on patients’ ability to continue their education
were also great. Seven of the eight patients stated that they would have liked
to "go to school" in the previous year, and all of these 7 patients reported that
sickle-cell disease had prevented them from doing so at some time.

When

these 7 patients were asked to describe the impact of the disease on their
ability to continue their education, 4 patients responded with "very7 large", one
with "large", one with "moderate", and one with "small".

Of the total 8

patients, one had completed a college education. 3 had started college but not
graduated, and 4 had graduated from high school.

In contrast, the impact of sickle cell disease on patients' ability to keep
house and do household chores did not appear as great.

Five of the 8

patients reported that their illness had prevented them from "keeping house"
at some time in the previous year, but the impact of the illness in this area
was judged to be "small" or "moderate" by 4 out of these 5 patients.

Patients mentioned periodic absences due to sickle crisis as a reason for
their difficulty with employment and with education, as in the following
remark:

"I can’t get the type of job I want - I need more training, but I
miss classes when I get sick, and I get behind."

Patients expressed frustration that in spite of periods of relatively good
health, recurrent pain crisis made regular employment or education very
difficult. This frustration was typified in the following remark:

"I always wanted to be like my sister and brother, but I couldn't - I’m much more dependent on my parents than they are. I really
want to start working, so that I can be more on my own. It’s hard
when you’re always sick."
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In general, therefore, patients considered themselves to be significantly
disabled, especially in employment and education.

Painful sickle crisis was

not just a periodically troublesome phenomenon in their lives, but a source
of more general difficulty. Though psychological issues of self-esteem and
dependence were not explored more deeply in the interviews, remarks such
as the one just cited make it clear that difficulties with employment and
education have wide-ranging psychological ramifications.

It should be pointed out that the patients interviewed were all frequent
visitors to the Emergency Department, and that their experieneces with
disability may not reflect the disability of sickle-cell patients in general.

8.)

Access to medical care

Patients reported generally good access to medical care.

Of the 8

patients interviewed, 7 had Medicare or Title 19 assistance, and 1 had
insurance with a private insurer. Yale-New Haven Hospital was the medicalcare facility preferred by all 8 patients; none had been forced to seek care
at Yale because financial constraints had prevented them from being seen
elsewhere.

Two of the patients had had difficulty in the past year paying for
medical care. In one case, a dispute with a private insurance company led to
difficulty paying, and in another case, a patient whose Medicare paid 80% of
hospital bills had difficulty paying the remaining 20%.

Only one patient

reported that a financial difficulty had actually impaired care. In this case,
the patient reported that because Title 19 would not pay for proprietary
Demerol, it was necessary to purchase the less expensive generic version.
Meperidine. Though the patient found generic meperidine to be ineffective,
the effect of this substitution was still judged to be "mild".
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These findings about access to health care among frequent visitors to
the Emergency Department will be important in considering the patientphysician relationship.

It is important to emphasize in any case that it was

not generally financial pressure which forced patients to seek care at YNHH
rather than at nearby community hospitals. Conversely, from the hospital’s
standpoint, it is important to note that even though only one of the eight
patients interviewed was working regularly (part-time), all had some form of
insurance, primarily governmental (Title 19. Medicare or both for 7 of the 8
patients).

Thus, care to these frequent ED visitors was not being supplied

'gratis' by the hospital.

9.)

Patients' overall perspective on the medical care system

In the final question of the interview, patients were asked to answer the
following question, designed to assess overall perspective on the medical care
system:

Which of the following statements comes closest to expressing
your overall view of the American health care system?

1)

(Poor)

(lg)

The American health care system has so much

wrong with it that we need to completely rebuild it.

2)

(Fair)

There are some good things in our health care

system, but fundamental changes are needed to make it
work better.

3)

(Good)

On the whole, the health care system works

pretty well and only minor changes are necessary to make it
work.
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Perhaps somewhat surprisingly, patients appeared to have a generally
favorable perspective on the medical care system.

Of the eight patients

interviewed, five patients answered "3", and three patients answered "2”. Thus
the majority of these patients, with their life-long exposure to the health care
system, remained convinced that "the health care system works pretty well
and only minor changes are necessary to make it work".

Discussion
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Discussion

The unifying hypothesis of the present study, first presented in the
"Introduction", may now be examined in light of the study’s results. The
hypothesis posits that a small subset of sickle-cell patients with especially
severe symptoms becomes known to the Emergency Department staff as
visiting the ED frequently and requiring large doses of narcotic analgesics for
painful crisis. Irrespective of the actual prevalence of drug dependence
among patients, suspicions of drug dependence may arise, leading to a
tendency among ED physicians to limit the prescription of narcotic analgesics
for sickle-cell patients in general. Underprescription of pain medication may
lead to requests for additional pain medication by patients, or to repeat ED
visits, and thus in turn to escalating suspicions of drug-seeking among ED
staff. In this way. suspicion of drug-seeking among ED staff and frustration
at lack of pain relief among patients may begin to fuel one another in a
continuing circle.

The present study aimed to investigate this hypothetical circle at several
points, and to gather the information necessary to organize management
interventions to interrupt it. Therefore, the first task at hand was to survey
the ED and other hospital services for use by patients with sickle-cell disease.
A computer survey identified all visits to the ED by sickle-cell patients over a
one-vear period (1 October 1989 to 1 October 1990).

The computer survey identified a total of 132 patients with sickle-cell
disease, with a mean age of 21 years. Of the 422 visits to the Emergency
Department accounted for by sickle-cell patients during the study year, 131
(31.0%) resulted in admission. These 131 ED admissions represented 79.9%
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of the 164 total admissions for the group. Admissions overall lasted an
average of 5.9 days each.

Results of the computer survey largely confirmed the hypothesis that
small numbers of very frequent visitors to the Emergency Department
accounted for a disproportionate number of visits. Among patients with 6 or
more ED visits during the study year. 6 younger patients (10% of all younger
patients) accounted for 50% of all ED visits by younger patients, whereas 13
adult patients (19% of all adult patients) accounted for 73% of ED visits by
adults. These results are consonant with previous studies of ER utilization by
"frequent visitors" with sickle-cell disease (129).

Results of the interviews with 6 adult patients who visited the adult
medical service of the Emergency Department frequently (6 or more times
during the study period) confirmed the hypothesis that considerable conflict
between patients with sickle-cell disease and physicians may develop over
issues of drug-seeking and drug dependence, especially in the Emergency
Department. Five of the six patients reported that they had experienced
difficulty obtaining sufficient pain relief during crisis at some time in the last
year, because "doctors did not believe that the patient needed more
painkiller". Patients reported that they felt that ED staff did not comprehend
the pain they experienced during crisis.

In addition, patients frequently felt

accused by ED staff, directly or indirectly, of drug-seeking or drug abuse.
These problems were not reported by patients to the same degree with the
hematology clinics or with the inpatient floors.

Two of the 8 patients interviewed, though both 23 years old, continued
to be seen by the pediatric service. These two p bents gave equally high
ratings to the pediatric ED, hematology clinic ana inpatient floors. Though
their number is too small to permit generalizations, it is interesting to note
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See, for example. Vichinsky (1982), p.329. Powers (1986). Also of interest are
Pierce (1990) and Selbst (1990).
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thai both patients expressed reluctance to be transferred to the adult medical
service of the Emergency Department, where they felt that a rushed
atmosphere prevailed, judging from conversations with adult sickle-cell
patients. It is important to note that pediatric sickle-cell patients at YNHH
are cared for by a special sickle-cell service overseen by pediatricians and
coordinated by a nurse-practitioner.

Time considerations did not permit interviews with sickle-cell patients
who visited the Emergency Department a moderate amount, for example,
between 1 and 5 times per year. These patients represent the great majority
of patients in the community with sickle-cell disease, and it would be very
useful to compare their experiences in the Emergency Department with those
of more "frequent visitors". As it is, it is not known whether conflicts which
develop between ED staff and ’frequent visitors" also affect the care received
by the great majority of sickle-cell patients. Follow-up studies will investigate
this hypothesis.

However, it is reasonable to suppose that conflicts with these

"frequent visitors" may color perceptions among ED staff of sickle-cell
patients in general.

Patients reported that the physicians who saw them in hematology clinic,
namely, hematology fellows and attendings, had a pivotal role in managing
their care.

Patients described long-term relationships with their hematology

attendings (from 2 years to decades), and reported generally positive
experiences in hematology clinic. Physicians from hematology clinic
frequently visited patients when they sought care in the Emergency
Department, and often interceded for patients in assisting them to obtain
adequate pain relief in the Emergency Department.

The Emergency Department physicians with whom patients described
the most conflict were almost universally members of the hospital housestaff.
In this context, it is important to note that the frequently exhausted
housestaff bear the brunt of caring for patients on the front lines , and are
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most directly subject to the frustrations of dealing with patients one-on-one.
At the same time, they necessarily have limited experience in dealing with
knotty issues such as possible drug-seeking and dissembling by patients,

In

addition, it is reasonable to suggest that housestaff, as young physicians, may
be uncomfortable in discovering the acute limitations of their profession in
curing the sick (B0).

In all these respects, the experience of housestaff is in

contrast with that of attending physicians (and, for that matter, hematology
fellows), who are somewhat protected from the stresses of daily life in the
ED, and who may be more comfortable dealing with the uncertainty and
limitations of clinical medicine.

It should be noted that Yale-New Haven Hospital is the only medical
facility in its area with a significant experience and expertise in treating
hematological diseases such as sickle-cell disease. The closest academic
hematology training programs outside of YNHH are in New York City,
Boston, or Farmington, Connecticut, all a considerable distance from New
Haven. Though patients in crisis in the New Haven area could also seek care
at nearby community hospitals, few of the patients interviewed actually did.
In fact, all 8 of the interviewed patients denied that they would have
preferred to be seen in some other hospital. This situation might have been
different in a larger city, in which patients who were dissatisfied with their
care in one Emergency Department could seek care at a variety of other
Emergency Departments at hospitals with expertise in hematology.

130

See esp. Mechanic (1%8) on issues of housestaff vs. attending physicians.
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Suggestions for improving care of sickie-cell disease

A.

Genera] considerations

From the standpoint of the Emergency Department, sickle-cell disease is
both similar to a number of other illnesses, and entirely unique. For
example, sickle-cell disease might be compared to other chronic, debilitating
illnesses with periodic exacerbations, such as asthma, diabetes, hemophilia,
migraine headaches or lower back pain. In each of these illnesses, as in
sickle-cell disease, patients may visit the Emergency Department with high
frequency over many years, and may present difficult problems of diagnosis
and treatment. However, sickle-cell disease distinguishes itself from these
illnesses by its intractability, its severe pain symptoms requiring treatment
with narcotic analgesics, and in the constant possibility of life-threatening
complications with each pain crisis. Thus. Emergency Department treatment
of sickle-cell disease faces relatively unique difficulties.

A number of possible steps might contribute to alleviating the present
situation of tension and conflict in the Emergency Department. Any program
to address the issue of acute care of sickle-cell patients must consider the
following points:

1)

Though the literature suggests that the great majority of sickle-cell
patients do not become dependent on pain medications, drug¬
seeking and drug dependence are possible among patients with
sickle-cell disease, given the chronic nature of sickle pain and the
need for narcotic analgesics.

Discussion
2)

Page

109

Patients with sickle-cell disease are often significantly disabled,
especially in employment and education, and have an increased
prevalence of psychosocial difficulties.

3)

The possibility of serious medical complications exists during every
painful crisis. Early detection of complications such as
osteomyelitis, for example, may greatly reduce final morbidity and
shorten the hospital course.

B.

Suggestion:

better coordination of care for sickle-cell patients

For all these reasons, coordination of the care of each patient with
sickle-cell disease - in the psychological, psychosocial, and medical realms is pivotal. At present, hematology fellows and attendings coordinate the care
of individual sickle-cell patients in the medical realm, but do not have the
resources coordinate care for the patient in the Emergency Department, nor
to coordinate psychological and psychosocial aspects of care. Sickle-cell
patients who seek care at the Emergency Department on a given day may be
able to speak with their primary hematology attending, but may also have to
be seen by whichever of the many hematology attendings and fellows is on
call that day. At present, there is no one person acquainted with sickle-cell
patients over the long term, who is able to act as a sort of "central
clearinghouse" in the management of their care.

One model for coordinating the care of patients with sickle-cell disease
is close at hand, and already operating on the pediatric service. Among
pediatric sickle-cell patients, care is organized by a special sickle-cell service
overseen by pediatricians and a coordinated by a nurse-practitioner. Within
this system, the special needs of sickle-cell patients can be addressed in an
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organized fashion, in the outpatient hematology clinics as well as in the
Emergency Department.

C.

Suggestion:

Management Protocols for pain management

At the level of the Emergency Department, the use of individualized
management protocols would assist in standardizing the care of sickle-cell
patients who frequently utilize emergency services, and in reducing confusion
and conflicts among different services over treatment of individual patients.
Such individualized management protocols, drawn up in consultation with
each patient and his or her hematologist, and updated as needed, would
provide a short summary of the patient’s history, specify the type and starting
doses of analgesics to be given for sickle-cell crisis, and list the names and
telephone numbers of physicians responsible for each patient’s care. Nurses
and house-staff would be instructed to consult the treatment protocol prior to
the initiation of any therapy for sickle-cell patients presenting for pain, and to
contact the patient’s primary physician during each ED visit.

In fact, the use of such management protocols has been sporadically
attempted in the Emergency Department of Yale-New Haven Hospital.
Approximately two years ago (ie approx. 1989), according to ED staff,
management protocols emphasizing the use of oral pain medications and
limiting the use of IM injections were instituted for several of the most
frequent ED visitors with sickle-cell disease. However, as described by ED
staff, such protocols were unsuccessful in reducing patients’ requests for
medication and repeat visits for pain relief. This lack of success was
attributed to the difficulty in enforcing such protocols, due to the fragmented
nature of care for sickle-cell patients and the day-to-day changes in the
hematologist on call. Thus, from the standpoint of ED staff, the key factor in
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the failure of such management protocols was the lack of a collective will to
enforce them, among ED staff and members of the Hematology Section.

It is also possible, in the hectic atmosphere of the Emergency
Department, that confusion over when and where to find such management
protocols may have contributed to their failure. One approach to this
problem would be to program the ED computer system to print a copy of the
management protocol at the time that each sickle-cell patient registers.

A pivotal point in designing a program to coordinate the care of sickle¬
cell patients is that the object is improved care, and not merely decreased use
of IM narcotic pain medications or decreased numbers of repeat visits. It is
imperative that patients in pain crisis receive adequate analgesia. The design
of a successful program will involve not only ED physicians, hematologists,
and nurses, but most importantly, the patients themselves. As such, the
design of each management protocol should take place with active
participation by the patient, in order to make the protocol a part of
therapeutic alliance, rather than an obstacle to receiving pain relief.

As was discussed in the literature review, success with management
protocols in reducing conflicts over drug-seeking and in reducing frequency of
ED visits has been reported in several studies at other institutions. In
Powers’ study (1986), 5 men with sickle-cell disease were identified as chronic
ED users; with these 5 patients, a management protocol was associated with
a reduced total number of ED visits (from 163 to 56 in 6-month periods
before and after institution of the program), reduced mean length of ED stay,
and reduced use of parenteral meperidine, as well as increased satisfaction
with care among both patients and ED staff. In Vichinsky et al’s study
(1982). a multidisciplinary, comprehensive pain program, which included a
management protocol for treatment of pain, was associated with a 58%
reduction in Emergency Department visit and a 44% decrease in pain-related
hospitalizations in 10 patients with sickle-cell disease.
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Management protocols drawn up even for a small subset of sickle-cell
patients at Yale-New Haven Hospital could have a large impact on their care.
Data from the present study indicate, for example, that only 5 patients at
Yale-New Haven Hospital accounted for nearly 53% of all ED visits by
sickle-cell patients over the study year. Thus, management protocols drawn
up for these 5 patients, if consistently and humanely applied, could reduce
confusion and conflict in over half of the 420-some visits to the ED by sickle¬
cell patients over the course of a typical year. One may be confident that
reduction in conflict over the treatment of these five "frequent visitors" will
result in improved care for other sickle-cell patients as well.
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2)

Fair

3)

in general,
Good

now is....

4)

(1)

Excellent

Where does the pt receive care? >>>>

Is Yale-New Haven Hospital the place where you usually go
when you want to see a doctor (about your sickle-cell
disease in general)?
1)

*** Q . 3

Yes

2)

No

Which doctor would you usually call or go to
you have a sickle-cell crisis?
1)
2)
3)
4)
5)
6)
7)
8)
9)
10)

*** Q. 4

first when

A doctor from Yale adult hematology clinic
A doctor from Yale Pediatric heme clinic
(Dr. Pearson and Suzanne et al)
a doctor from a clinic at Saint Raphael's Hosp.
a doctor from a clinic at Bridgeport Hosp.
a doctor from a clinic at Hill Health Center
A private doctor
An HMO
Other:
_
YNHH Emergency Room
Some other Emergency Room
(which one?_)
Is your sickle-cell disease followed over time by a
hematologist or hematologists, that is, by a doctor who
specializes in blood diseases?

a)

1)

b)

(if

Yes

2)

No

YES)

Where does this hematologist work?

1)
2)

Yale adult hematology clinic
Yale
pediatric
hematology
clinic
Suzanne et al)
Saint Raphael's
Bridgeport
Hill Health Center
A hematologist in private practice
own office)
A hematologist working with an HMO
Other hematologist

4)
5)
6)
3)
4)
5)

(Dr.

Pearson,

/
/

(in

his

or

her
>
<
\

Question List
***

Q. 5
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Is there any other hospital or clinic where you have gone
for medical care of your sickle-cell disease in the last
year, that is, since (present month) of last year?

a)

1)

b,c)

(If

Yes
YES)
1)
2)
3)
4)
5)

d)

Revision date:

2)

No

Which one

is that?

(circle all

that apply)

Saint Raphael's
Bridgeport
Hill Health Center
Other hosp.
Other hosp.

How many times have you been seen at this hosp/clinic
the past year?

(s)

in

Have you seen a private doctor (in his own office, not in
a hospital) about your sickle-cell disease in the past
year ■p

Q.6

Yes

2)

No

a)

1)

b)

(If

c)

How many times have you seen this private doctor in
(If YES)
the past year?

YES)

Where does he or she practice?

Question List
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<<<<
*** Q.7

a)

2 February 1991

Hematology Clinic

>>>>

Have you been to the hematology clinic (pedi or
adult) at YNHH in the past year, that is, since
January of last year?
Y/N

b)

Were you seen in the pediatric or the adult hematology clinic?
Pedi
/
Adult

c)

When was the last time you went to Hematology Clinic at Yale,
approximately?
_

(if pt has not been at YNHH hematology clinic
the past year, skip to the next section)

*** Q.8

(adult or

pedi)

in

When you visit the hematology clinic at Yale, is there
one particular clinic doctor who manages your care as
your primary doctor?
(23b)
Yes

a)

1)

b)

(If Yes)

2)

No

3)

Not applicable

How long has this doctor been seeing you in clinic?
years/months/weeks

c)

(If YES)
How well does this
problems?
1) Poor
2) Fair

doctor
3)

understand your medical

Good

4)

Excellent

*** Q.9

In general, how well do the doctors in clinic explain to
you what is going on with you medically?
1) Poor
2) Fair
3) Good
4) Excellent

*** Q.10

In general, how well do the doctors
as taking enough time to see you?
1) Poor
2) Fair
3) Good

*** Q.ll

in clinic do as
4)

far

Excellent

In general, how well do doctors in clinic do at treating
the pain of your sickle-cell crises?
1) Poor
2) Fair
3) Good
4) Excellent

Question List

Page

6

1)

a)

Yes

(If YES)

February 1991

2)

No

3)

N/A

What have been the sources of the difficulty?
(check all
that have been sources
of
difficulty in the past year)

b)

Financial reasons — pt could not afford to be seen
(Y/N)

c)

Doctors
did
not
painkiller
(Y/N)

d)

Other reason

(If YES to a) )
experienced this
clinic?
1)

*** Q.13

2

In the past year, when you have visited the Hematology
Clinic at Yale, have you had any difficulty obtaining a
prescription for all the painkiller you needed?

*** Q.12

e)

Revision date:

only seldomly

Explain

believe

that

pt

needed

for not receiving painkiller

more

(Y/N)

In the past year, how often have you
difficulty obtaining painkillers
in

2)

Fairly often

3)

Very often

(comments on clinic experiences):

Question List
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Revision date:

<<<<<
*** Q.14

a)

2 February 1991

Emergency Room

>>>>>>

Have you been to the Emergency Room at YNHH
or adult) at YNHH in the past year, that is,
January of last year?
Y/N

(pedi
since

b)

(If YES)
Were you seen on the pediatric or the adult side of
the Emergency Room?
Pedi / Adult

c)

When
was
the
approximately?

last
time
_

(if pt has not been at YNHH
skip to the next section)
*** Q.15

ER

you

went

(adult or

to

the

pedi)

ER

in the

at

Yale,

past year,

When you visit the Emergency Room at Yale, is there one
particular emergency room doctor who manages your care as
your primary doctor? (that is, one who works primarily in
the ER, not someone, for example, from hematology clinic
who comes down to the ER to see you)
(23b)

a)

1)

b)

(If

Yes
Yes)

2)

No

3)

Not applicable

How long has this
Emergency Room?

doctor

been

seeing

you

in

the

years/months/weeks

c)

(If

YES)

1)
*** Q. 16

*** Q. 17

How well does this emergency room doctor understand
your medical problems?
Poor

2)

Fair

3)

Good

4)

Excellent

(If patient has a relationship with a Yale clinic doctor
— see answer to Q.4)
When you visit the ER at Yale, how often does your doctor
from the hematology clinic come to see you in the ER?
0)

N/A

1)

Never

2)

Sometimes

3)

Usually

4)

Always

In general, how well do the doctors in the Emergency Room
explain what is going on with you medically?
1)

Poor

2)

Fair

3)

Good

4)

Excellent

Question List
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*** Q. 18

In general, how well do the doctors in the Emergency Room
do as far as taking enough time to see you?
1) Poor
2) Fair
3) Good
4) Excellent

*** Q.19

In general, how well do doctors in the emergency room do
at treating the pain of your sickle-cell crises?
1)

*** Q.20
a)

b)

Poor

2)

Fair

3)

Good

4)

Excellent

In the past year, when you have visited the Emergency
Room at Yale, have you had any difficulty obtaining a
prescription for all the painkiller you needed?
1)

Yes

(If

YES)

2)

No

3)

N/A

What have been the sources of the difficulty?
(check all
that have been
sources
of
difficulty in the past year)

Financial
(Y/N)

reasons

not

pt

believe

could

that

pt

not

afford

needed more

to

be

seen

c)

Doctors
(Y/N)

d)

Other reason

e)

In the past year, how often have you experienced thi
difficulty obtaining painkillers in the Emergency Room.

for not receiving painkiller

painkiller

(Y/N)
o to

1)

*** Q.21

did

—

only seldomly

Explain

2)

(comments on

Fairly often

3)

ER experiences):

Very often

Question List
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Revision date:
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*** Q.22

a)

2 February 1991

Inpatient care

>>>>

Have you been admitted to the hospital at YNHH for
sickle-cell disease
in the past year,
that is,
since January of last year?
Y/N

b)

Did you stay on the pediatric wards,
Pedi
/
Adult

or on the adult wards?

c)

When was the last time you were admitted
Hosp., approximately?
_

at

Yale-New

(if pt has not been admitted at YNHH in the past year,
next section)

*** Q.23

Poor

2)

Fair

3)

Good

4)

Excellent

In general,
when you are admitted,
how well do the
doctors in the hospital do as far as taking enough time
to see you?
1)

*** Q. 2 5

skip to the

In general, when you are admitted at YNHH, how well do
the doctors in the hospital explain to you what is going
on with you medically?
1)

*** Q. 24

Haven

Poor

2)

Fair

3)

Good

4)

Excellent

In general, when you are admitted, do doctors and nurses
in the hospital do well at treating the pain of your
sickle-cell crises?
1)

Poor

2)

Fair

3)

Good

4)

Excellent

Question List
*** Q.26

a)
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In the past year, when you have admitted at Yale-New
Haven Hospital, have you had any difficulty obtaining a
prescription for all the painkiller you needed?
1)

Yes

2)

(If YES)

No

3)

N/A

What have been the sources of the difficulty?
(check all
that have been
sources of
difficulty in the past year)

b)

Financial
(Y/N)

c)

Doctors
(Y/N)

d)

Other reason

e)

In the past year, how often have you experienced this
difficulty obtaining painkillers while admitted overnight
in the hosptal?
1)

*** Q.27

reasons

did

pt

not believe

could

that

pt

not

afford

needed more

for not receiving painkiller

only seldomly

Explain

—

2)

Fairly often

3)

to

be

seen

painkiller

(Y/N)

Very often

(comments on experiences while admitted):

Question List
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1)
4-1
H

d

1)
2)
3)
4)

Yes
YES)

2)

No

Are you following the doctor's instructions?

hardly ever or not at all
sometimes
usually
always

Have your doctors advised you to drink a lot of water or
take other steps to avoid sickle crises?
(adapted from
6 9a)

*** Q.29

a)

1)

b)

(If YES)
1)
2)
3)
4)

*** Q.30

Yes

2)

No

Are you following the doctor's instructions?

hardly ever or not at all
sometimes
usually
always

In general, do you follow the recommendations given to
you by your doctors?
1)
2)
3)
4)

*** Q.31

>>>>>

Have your doctors advised you to cut down on activities
such as sports or heavy work because of your sickle-cell
disease?
(68f)

*** Q.28

a)

Compliance

2 February 1991

hardly ever or not at all
sometimes
usually
always
(open question)

Why or why not?

(and in which ways)

Question List

Page
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Revision
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***

Q.32

a)

Working

at

a

job

on
1)
keeping

1)

Going

>>>>

business?

last year,

(70b)

No

3)

N/A

How great an impact has sickle-cell disease had

your ability to work at a job
small
2) moderate
3) large
house?

small

to
1)

1)

or business?
4) very large

(70d)

2)

moderate

school?
Yes
2)

small

Carrying
1)

h)

3)

(70f)
No

large

3)

4)

very

large

N/A

2)

out

your

Yes

2)

moderate

normal

3)

large

activities

4)

in

any

very

large

way?

(70j)

No

(If YES)
How great an impact has sickle-cell disease had
on your ability to carry out your normal activities?
1)

Q.3 3

small

Are

you

2)

moderate

employed
employed

3)
4)

temporarily
retired

5)
6)

not usually employed
on disability

7)

keeping

8)

other

a)

3)

currently....

1)
2)

full
part

large

4)

very

large

(83a)

time
time

out

of

work

house/homemaker

(specify:_

<<<<<<<<

*** Q.34

1991

(If YES)
How great an impact has sickle-cell disease had
on your ability to go to school?

f)

***

Disability

February

1)
Yes
2)
No
3)
N/A
(If YES)
How great an impact has sickle-cell disease had
on your ability to keep house?

d)

g)

or
2)

(If YES)

b)

e)

2

In the last year, that is, since (this month)
has sickle-cell disease prevent you from...

1) Yes

c)

date:

During

the

Pain

last

medication

year,

how

many

>>>>>>>
months

out

of

the

year have you needed to take at least some pain
medication (for sickle-crisis or for between-crisis
pain)?
(answer

from

1

to

12)

Question List

Page 13

b) (Pain leds,
needed pain
hospital?
1)
2)
3)
4)

Revision date:
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cont'd)
In the past
medication at home.

year, how often have
when you are not in

you
the

Never
or hardly ever
Occasionally (once a month or several months)
Fairly
frequently
(several
times
per
week
several weeks)
All or most of the time (most days)

or

c)

(If yes to b)
When you have pain, which pain medication
do you usually actually take for the pain you have at
home?
(drug, dose and route)
_

d)

(If yes to b)
Which pain medication works best for this
pain you have at home? (ie, which pain medication would
you prefer to get?)
(drug, dose and route)
_

e) When you have a bad sickle-cell crisis,
do you prefer to get (and how much):
(drug,

which pain medication

dose and route)

f) When you have sickle-cell pain crisis, how effective
narcotic medication in stopping the pain you feel?
0)
Not effective at all
1)
a little effective
3)
moderately effective
4)
very effective
(record N/A if pt has not tried this method)
g)

h)

is

FV

When you have sickle-cell pain crisis, how effective
narcotic medication in stopping the pain you feel?
0)
Not effective at all
1)
a little effective
3)
moderately effective
4)
very effective
(record N/A if pt has not tried this method)

is oral

When you have sickle-cell pain crisis, how effective
narcotic medication in stopping the pain you feel?
0)
Not effective at all
1)
a little effective
3)
moderately effective
4)
very effective
(record N/A if pt has not tried this method)

is non¬

i) comments on pain medication:

/

|

Page 14
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***

Q.35

a)

1)

b)

(for YES
go?

Definitely

code

2)

and PERHAPS
(32B)

YES

and

only)

PERHAPS

answer:

(all

that

Health

4)

Regular

5)
6)

Referred by some
Other reason

or

doctor/HMO

3)

Where would you have

Why

didn't

afford

No difficulty

HMO
etc

covers
was

other

b)

(If

code

answer:
1)
Financial

2

or

3)

Why

2)

not

Had

no

3)

not cover all costs
Other (will add codes
the

past

needed
a)

1)

b)

(If

1)

year,
felt

Yes
YES)

mild

Explain

health
as

was

you
2)

only

patients

to

YNHH

in the

3)

past year paying

A lot of difficulty

couldn't
or

afford

payments

HMO,

but

this

when

the

costs

did

appropriate)

there

any

time

from getting all

needed)

at

of

the care you

YNHH?

No

How

much

of

the

care

you

effect

else

seeing

insurance

care prevented you
(or

(32e)

provider

insurance,

2)

In

there?

that?

for medical care
Financial — Had

medical

go

preferred to

visits

Some difficulty

was

--

you

someplace

How much difficulty have you had
for your medical care at YNHH?
1)

No

apply)

3)

insurance

Perhaps

only)

Financial — couldn't
Transportation

a)

*** Q.38

yes

1)
2)

*** Q.36

Q.37

>>>>>

In general, would you prefer to go somewhere else other
than Yale-New Haven Hospital ER or clinic to receive your
care?
(32a)

c) (for

***

Access

2 February 1991

2)

an

effect

do

you

think

this

had

received?

Strong

(open guestion):

effect

3)

Severe

effect

Question List
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Q. 39

BACKGROUND

0)

None
Elementary

1

year
2
3
4
5
6
7
8

2)
3)

4)
5)

6)
7)
High

school

12)

H.S.

grad

13)
14)

College

1991

>>>>>>

years
years
years
years
years
years
years

12

years
13
14
15

years
years
years

15)
16)

College

17)
18)

Some graduate school
Graduate or professional

Q.40

grad.

What
1)

Single

is

16

your

—

2)
3)

married
divorced

4)

widowed

<<<<
***

February

9 years
10 years
11 years

ID

***

2

What is the highest year in your education which you have
completed?
(eg, in elementary school, high school, or
college) (81 )

1)

8)
9)
10)

date:

Q.41

Which

of

years

marital

never
or

st

married

separated

Overall
the

Perspective

following

>>>>

statements

comes

closest

to

expressing your overall view of the American health care
system?
1)
it

(Poor)
that we

(lg)

The American health care system has
need to completely rebuild it.

so much wrong with

2)
but

(Fair)
There are some good things in our health care system,
fundamental changes are needed to make it work better.

3)
and

(Good)
On the whole, the health care system works pretty well
only minor changes are necessary to make it work.

Time at this point:

/

/
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